Document:

EXHIBIT 10(r)
                                                                   -------------

Confidential Treatment Requested as to certain information contained in this
Exhibit 10(r) and filed separately with the Securities and Exchange Commission

                             WAFERS SUPPLY AGREEMENT
                                 March 16, 2006

1.   THE PARTIES

     Spire Corporation (the "Seller"), a business incorporated in the
     Commonwealth of Massachusetts, with its principal place of business at One
     Patriots Park, Bedford, Massachusetts, 01730-2396, U.S.A.;

     *** (the "Buyer"), a business organized under the laws of ***, with a
     principal place of business at ***.

2.   OBJECT OF AGREEMENT

     Seller agrees to supply at Buyer's site a maximum of approximately
     4,500,000 wafers, a volume which should approximate a cell electrical
     capacity of ***MW, such wafers shall be either mono-crystalline or
     multi-crystalline wafers, and based upon wafers sizes of 100mm, and/or
     125mm and/or 156mm with a silicon minority carrier life time specified by
     Seller, hereinafter "wafers". It is understood that the intent of this
     supply is to allow Buyer to produce approximately ***MW of cells with an
     electrical efficiency of 15% through the Photovoltaic Cell Manufacturing
     Line (the "Manufacturing Line") to be supplied and installed by Seller at
     Buyer's site pursuant to the Turn-Key Project Agreement signed today
     between the Seller and the Buyer.

3.   SUPPLY TERMS

     Seller commits to supply Buyer said maximum of approximately 4,500,000
     wafers, a volume which should approximate a cell electrical capacity of
     ***MW to be used by Buyer for the production of the cells through the
     Manufacturing Line during the first three quarters of 2007 ("Maximum Term
     of Supply of Wafers").

     Unless otherwise agreed between the Parties, Seller shall supply said
     wafers within the Maximum Term of Supply of Wafers on the basis of a
     minimum supply of ***MW and a maximum supply of ***MW per each of the said
     three quarters of 2007. Buyer shall confirm to Seller the amount of wafers
     to be supplied through specific written orders. Said supply orders shall
     include (i) quantity of wafers ordered (ii) date of delivery (iii) purchase
     price (iv) payment conditions and (v) technical specifications of the
     wafers ordered.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        1
<PAGE>

     Before Seller purchases from any third party (supplier, sub-vendor, etc.)
     the wafers to be supplied to Buyer pursuant to this Agreement, Seller
     should notify Buyer the terms and conditions of such purchase. Buyer shall
     provide approval for the purchase of said wafers within a maximum of 1
     month as of the date Seller requested its approval for the purchase. Such
     approval will not be unreasonable withheld.

     This Seller's supply obligation may be cancelled by Buyer, provided that
     Buyer gives Seller, at least, one (1) month's written notice of
     cancellation from the date Buyer ordered the wafers from Seller.

     During the whole Maximum Term of Supply of Wafers, Buyer shall be freely
     entitled to purchase the wafers from other suppliers. In such case,
     Seller's obligation to supply wafers shall be reduced proportionally in the
     same amount of wafers to be purchased by Buyer from other suppliers.

     The quality of the wafers supplied by Seller to Buyer pursuant to this
     Agreement must be sufficient to guarantee that the Manufacturing Line
     produces cells with a 15% electrical efficiency, as further defined in the
     Turn-Key Project Agreement signed today.

4.   PRICE AND TERMS OF PAYMENT

     The purchase price of the wafers shall be agreed between Seller and Buyer
     for each supply on the basis of the wafers worldwide market conditions,
     failing which purchase price of the wafers shall be fixed by the parties on
     the basis of the average purchase price of major recognized international
     wafers vendors, including but not limited to following vendors: ***. Upon
     receipt of the quotation of such vendors either Party will inform the other
     party of the appropriate purchase price.

5.   WARRANTY

     Seller sells the wafers with a Warranty as shown in Attachment A hereto. It
     is this Warranty and no other that shall apply to any claims of defects in
     the wafers, save for any mandatory product liability rules applicable in
     the jurisdiction of the Buyer.

6.   INDEMNITY

     Seller shall indemnify, defend, protect and hold harmless Buyer from any
     action, suit, complaint, allegation and controversy of whatever kind
     directed against Buyer which originates on a violation or infringement of
     any and all invention rights, patents, designs, copy-rights, trademarks,
     service marks, data basis, topographic rights, trade secrets, know how and
     other similar rights which may apply to the wafers supplied by Buyer,
     whether or not such rights have been registered.

     Buyer shall indemnify, defend, protect and hold harmless Seller from any
     action, suit, complaint, allegation and controversy of whatever kind which
     originates in Buyer's for the sale or use of any products that was
     manufactured using the wafers, provided that Buyer failed to follow the
     instructions for use provided by Seller in their entirety, and provided
     also that no portion of the cause has its origin in any act of gross
     negligence on the part of Seller.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                       2
<PAGE>

7.   CONFIDENTIALITY

     Certain matters regarding this relationship embodied by this Agreement may
     be considered confidential or sensitive to one or the other Party to this
     Agreement. The Parties agree that all such matters, once identified, will
     be treated in accordance with the Confidential Disclosure Agreement
     attached hereto as Attachment B. This Agreement does not confer any right
     of ownership to any technical data disclosed to Buyer for Process
     Technology development purposes, and Buyer shall not release any technical
     data to any third party without the written approval of Seller.

8.   GENERAL PROVISIONS

     a. No Waiver - Waiver of any provision of this Agreement, in whole or in
     part, in any one instance shall not constitute a waiver of any other
     provision in the same instance, or any waiver of the same provision in any
     other instance, but each provision shall continue in full force and effect
     with respect to any other then-existing or subsequent breach.

     b. Notice - Any notice required or permitted under this Agreement shall be
     given in writing to the Parties at their respective addresses as specified
     above, or at such other address for a Party as that Party may specify by
     notice (i) by delivery in hand or, (ii) registered or certified mail,
     return receipt requested, or courier or some other form of expedited
     delivery service that provides for delivery to the sender of a signed
     receipt. Notice so sent shall be effective upon receipt unless otherwise
     specified herein or in the notice.

     c. Arbitration of Disputes - All disputes arising out of or in connection
     with this Agreement that cannot be readily or amicably solved by the
     Parties shall be finally settled pursuant to the Rules of Arbitration of
     the International Chamber of Commerce by three arbitrators appointed in
     accordance with said rules. The place of arbitration shall be *** and the
     arbitration shall be conducted in the English language.

     d. Force Majeure - Neither Party to this Agreement shall be responsible to
     the other Party for delays or errors in its performance or other breach
     under this Agreement occurring solely by reason of circumstances beyond its
     control, including acts of civil or military authority, national
     emergencies, fire, labor disputes, flood or catastrophe, acts of God,
     insurrection, war, riots, severe weather, or failure of transportation,
     communication or power supply.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        3
<PAGE>

     e. Miscellaneous - This Agreement: (i) may be executed in any number of
     counterparts, each of which, when executed by both Parties to this
     Agreement shall be deemed to be an original, and all of which counterparts
     together shall constitute one in the same instrument; (ii) shall be
     governed by and construed under the laws of the ***, without application to
     the principle of conflict of laws; (iii) except and to the extent expressly
     provided for in Article 11, this Agreement constitutes the entire agreement
     between the Parties with respect to its subject matter, superceding all
     prior oral and written (except as previously noted) written communications,
     proposals, negotiations, representations, understandings, courses of
     dealing, agreements, contracts, and the like between the Parties in such
     respect; (iv) may be amended, modified, and any right under this Agreement
     may be waived in whole or in part, only by a writing signed by both
     Parties; (v) contains headings only for convenience, which headings do not
     form part, and shall not be used in construction, of this Agreement; (vi)
     shall bind and inure to the benefit of the Parties and their respective
     legal representatives, successors and assigns, including, without
     limitation, to a Parties corporate parents or affiliates, provides that no
     Party may delegate any of its obligations under this Agreement or assign
     this Agreement except to a related entity or successor by sale or merger,
     without prior written consent of the other party. This Agreement is in the
     English language only which language shall be controlling in all aspects.

     f. In the event either Party is in default for hundred and twenty (120)
     days in any obligation hereunder, and the other Party has given written
     notice specifying the claimed particulars of such default, which shall
     continue for a period of thirty (30) days after the date of such notice,
     the party giving notice may thereupon terminate this Agreement forthwith by
     giving the other Party ten (10) days written notice of termination.

9.   UNITED STATES EXPORT REGULATIONS

     Seller is subject to the Export Regulations of the United States Department
     of Commerce and other regulatory agencies that regulate the export from the
     United States of certain technical data and information. Because of these
     regulations, the Parties to this Agreement recognize that Seller can
     furnish such technical data to Buyer only on the condition that Buyer not
     re-export the technical data and/or information to any country to which
     Seller may not, without a validated export license, export such data
     directly.

10.  COMPLIANCE WITH LAWS GENERALLY

     Both Parties agree that they will diligently comply with all relevant laws,
     statutes, orders and administrative regulations of all relevant
     jurisdictions, at all relevant times. Each Party additionally agrees to
     indemnify and hold the other Party harmless from any governmental action at
     law that results from the willful or negligent failure of the indemnifying
     Party to comply with any relevant law, statute, order or administrative
     regulation. The Parties hereby certify that they are, to the best of their
     knowledge, compliant with all such laws, statutes, orders, and
     administrative regulations.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        4
<PAGE>

11.  ASSIGNMENT

     This Agreement shall not be assignable by either Party hereto without the
     express prior written consent of the other Party, except that it may be
     assigned without such consent to the successors to and assigns of
     substantially the entire assets and business of such Party. No assignment
     hereof shall be valid without the assumption in writing by such successors
     or assigns of all obligations under this Agreement. When duly assigned in
     accordance with the foregoing, this Agreement shall be binding upon and
     inure to the benefit of the assignee.

IN WITNESS WHEREOF, the Parties hereto have set their respective hand and seals
signifying their concurrence and endorsement with and of the foregoing, in a
number of counterpart copies, each of which shall be deemed to be an original
for all purposes and deemed effective and binding on the date at the head of
this document.

***

/S/     ***
-------------------------------
By:     ***
Title:  ***
Place:  ***
Date:   March 16, 2006

Spire Corporation

/s/ Rodger W. LaFavre
-------------------------------
By:    Rodger W. LaFavre
Title: Chief Operating Officer, Spire Corporation
Place: Bedford, Massachusetts, U.S.A.
Date:  March 16, 2006

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        5
<PAGE>

                                  ATTACHMENT A

                 STANDARD WARRANTY FOR WAFERS SUPPLIED BY SPIRE

Seller's Warranty: Seller warrants the wafers against defects and workmanship
and warrants that the wafers will meet the quality and technical specifications
agreed by the Parties in this Wafers Supply Agreement. Seller's warranty is
limited to the replacement of those wafers which do not meet said quality and
technical criteria, including labor, for a period of one (1) year after the date
of supply of the wafers to Buyer, or until such wafers are utilized by Buyer in
the Manufacturing Line, whichever comes first. This warranty is void where it is
determined that the wafers in question were subject to accident, negligence,
misuse, using the Manufacturing Line for purposes other than what it was
supplied for, or not maintaining the wafers in accordance with the
specifications and instructions provided by Seller.

                                        6
<PAGE>

                                  ATTACHMENT B

                        CONFIDENTIAL DISCLOSURE AGREEMENT

AGREEMENT made this 18th day of January 2006 between SPIRE CORPORATION, One
Patriots Park, Bedford, Massachusetts, 01730-2396 (hereinafter called "SPIRE"),
and *** (hereinafter called "COMPANY").

WHEREAS, COMPANY and SPIRE have represented to each other that each owns, may
own or is interested in receiving Proprietary Information (as defined below)
pertaining to: The design, engineering, manufacture and marketing of wafers to
be used by Buyer for the production of cell through the Photovoltaic Cell
Manufacturing Line as further described in the Turn-Key Project Agreement
executed today between the parties to which this Agreement is attached to.

WHEREAS, COMPANY and SPIRE intend to exchange Proprietary Information for the
following purpose(s): Establishment, development and maintenance of a
vendor-customer relationship.

NOW, THEREFORE, for the good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby agree as
follows:

1.   DEFINITION

     For purposes of this Agreement, "Proprietary Information" means data,
     reports, specifications, designs, phototypes, test results, trade secrets,
     processes, patentable inventions, plans and other business, financial ort
     technical information in written, electronic magnetic or oral form (i)
     which is known only to the disclosing party, (or to others to whom the
     disclosing party has voluntarily disclosed it subject to restrictions
     similar to those set forth in this Agreement); (ii) as to which the
     disclosing party has taken reasonable precautions against disclosure; and
     (iii) which has been clearly labelled by the disclosing party as
     "confidential", "proprietary", "secret" or other term or similar import.
     Orally disclosed Proprietary Information shall retain its character as
     Proprietary Information so long as the proprietary, protected nature of the
     disclosed information is conveyed to the recipient: (a) orally at the same
     meeting or in the same conversation as the Proprietary Information is
     discussed and in writing within thirty (30) days of the original
     disclosure; or (b) in writing only, within ten (10) days of the original
     disclosure, in which case the recipient shall not be held liable for any
     disclosure of the Proprietary Information prior to it being so labelled.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        7
<PAGE>

2.   Obligation to Protect Proprietary Information

     a.   Each party agrees that if it is a recipient under this Agreement, it
          will not publish or otherwise disclose Proprietary Information
          received from the disclosing party to any third party or to any person
          employed by the recipient other than those who have a "need to know"
          in order to evaluate Proprietary Information and make the decisions
          contemplated by this Agreement. Any employee, consultant or other
          agent to whom a recipient party discloses Proprietary Information
          received for a disclosing party as provided in this Agreement, shall
          be subject to confidentiality obligations to such recipient party
          covering the Proprietary Information to at least the same extent as
          the recipient party is obligated by this Agreement. Each recipient
          party agrees to exercise reasonable care to protect the disclosing
          party's Proprietary Information and shall utilize the same procedures
          and systems to protect such Proprietary Information as it utilizes to
          protect its own Proprietary Information and other proprietary data.

     b.   Each party agrees to use Proprietary Information received from the
          other party only for the purposes described in this Agreement.

     c.   Immediately upon the request of the disclosing party, the recipient
          shall return to the disclosing party any of the disclosing party's
          Proprietary Information so requested without retaining any copies
          thereof. Upon termination of the relationship or discussions
          contemplated by this Agreement, all Proprietary Information shall be
          returned by the recipient to the disclosing party without retaining
          any copies thereof.

     d.   Unless otherwise stated in writing signed by the parties, a
          recipient's obligation to protect Proprietary Information shall
          continue for five (5) years from disclosure.

     e.   Company further agrees that it will at no time during the five (5)
          years from the date written above use its access to Spire employees as
          an opportunity to solicit their employment elsewhere on Company's or
          any other party's behalf and for any purpose.

3.   Limitations on the Parties' Obligations

     No obligation to protect Proprietary Information shall exist under this
     Agreement with respect to any information which: (a) at the time of
     disclosure is in the public domain, (b) enters the public domain through no
     act or failure to act by the recipient, (c) comes into the possession of
     the recipient from a third party without obligation on the recipient to
     maintain it in confidence, or (d) at the time of disclosure to the
     recipient was already known to the recipient as evidenced by appropriate
     documentation.

4.   Effect of Agreement

     All Proprietary Information remains the property of the disclosing party at
     all times. This Agreement does not constitute the promise or intention of
     either party to buy, or sell or market any products or services or to enter
     into any other type of arrangement or agreement. This Agreement does not
     constitute or imply the grant of any license or permission to use any
     intellectual property or Proprietary Information except to the limited
     extent and for the limited purposes set forth herein.

                                        8
<PAGE>

5.   Miscellaneous

     Any failure by either party to enforce its rights under this Agreement in
     any one instance shall not constitute a waiver of those rights in any other
     instance. The Parties acknowledge that a breach of this Agreement by a
     recipient may result in irreparable harm to the disclosing party not easily
     measured in monetary damages alone. Therefore, in addition to all other
     remedies available at law, the parties consent to the imposition of
     equitable remedies including injunctive relief without the necessity of
     proof of actual damages. This agreement shall be governed and construed
     under the laws of the ***.

6.   Term

     The term of this agreement shall be three (3) year(s) from the date written
     above, except as to the obligations set forth in paragraph 2.

*** Represents text omitted pursuant to a request for confidential treatment.
The omitted material has been filed separately with the Securities and Exchange
Commission.

                                        9EXHIBIT 10.1
                                                                    ------------

                          AGREEMENT AND PLAN OF MERGER

                                  BY AND AMONG

                                  IVOICE, INC.

         THOMAS PHARMACEUTICALS, LTD. (F/K/A IVOICE ACQUISITION CORP.).,

                          THOMAS PHARMACEUTICALS LTD.,

                             FARRIS M. THOMAS, JR.,

                                  JOHN E. LUCAS

                 AND EACH OF THE OTHER SHAREHOLDERS NAMED HEREIN

                           Dated as of January 6, 2006

<PAGE>
                                TABLE OF CONTENTS

                                                                            Page

ARTICLE I          THE MERGER.................................................2

   SECTION 1.01.   The Merger.................................................2
   SECTION 1.02.   Effective Time.............................................2
   SECTION 1.03.   Effect of the Merger.......................................2
   SECTION 1.04.   Certificate of Incorporation; By-laws......................2
   SECTION 1.05.   Directors and Officers.....................................3
   SECTION 1.06.   Conversion of Shares.......................................3
   SECTION 1.07.   Delivery by Shareholders of the Shares at Closing..........4
   SECTION 1.08.   No Further Ownership Rights in Company Common Stock........4
   SECTION 1.09.   Taking of Necessary Action; Further Action.................5
   SECTION 1.10.   Material Adverse Effect....................................5

ARTICLE II         REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS AND
                   THE COMPANY................................................5

   SECTION 2.01.   Organization and Qualification; Subsidiaries...............5
   SECTION 2.02.   Certificate of Incorporation and By-laws...................6
   SECTION 2.03.   Capitalization.............................................6
   SECTION 2.04.   Authority Relative to This Agreement.......................6
   SECTION 2.05.   Material Contracts; No Conflict; Required Filings and
                   Consents...................................................7
   SECTION 2.06.   Compliance; Permits........................................8
   SECTION 2.07.   Financial Statements.......................................8
   SECTION 2.08.   Absence of Certain Changes or Events; Company Actions......8
   SECTION 2.09.   No Undisclosed Liabilities................................10
   SECTION 2.10.   Absence of Litigation.....................................10
   SECTION 2.11.   Employee Benefit Plans; Employment Agreements.............10
   SECTION 2.12.   Employment and Labor Matters..............................10
   SECTION 2.13.   Restrictions on Business Activities.......................11
   SECTION 2.14.   Title to Property.........................................11
   SECTION 2.15.   Taxes.....................................................11
   SECTION 2.16.   Environmental Matters.....................................12
   SECTION 2.17.   Brokers...................................................13
   SECTION 2.18.   Intellectual Property.....................................14
   SECTION 2.19.   Certain Business Practices................................19
   SECTION 2.20.   No Bankruptcy.............................................19
   SECTION 2.21.   Title to Properties; Absence of Encumbrances..............19
   SECTION 2.22.   Real and Personal Property................................19
   SECTION 2.23.   Transactions with Affiliates; Management Relationships....20
   SECTION 2.24.   Insurance.................................................20
   SECTION 2.25.   Books and Records.........................................20
   SECTION 2.26.   Accounts Receivable.......................................21
   SECTION 2.27.   Customers and Suppliers...................................21
   SECTION 2.28.   Employee Conflicts........................................21
   SECTION 2.29.   Bank Accounts.............................................21
   SECTION 2.30.   No Required Disclosure....................................21
   SECTION 2.31.   Internal Controls.........................................21

                                        i
<PAGE>

                                TABLE OF CONTENTS
                                   (continued)

   SECTION 2.32.   Inventory.................................................22
   SECTION 2.33.   Product Liability.........................................22
   SECTION 2.34.   True and Complete.........................................22

ARTICLE III        REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB...22

   SECTION 3.01.   Organization and Qualification; Subsidiaries..............22
   SECTION 3.02.   Authority Relative to This Agreement......................23
   SECTION 3.03.   No Conflict...............................................24
   SECTION 3.04.   Authorization and Validity; Issuance of Shares............24
   SECTION 3.05.   Absence of Litigation.....................................24
   SECTION 3.06.   Ownership of Merger Sub...................................24
   SECTION 3.07.   Ownership of Shares.......................................24

ARTICLE IV         SHAREHOLDER REPRESENTATIVE................................25

   SECTION 4.01.   Appointment...............................................25
   SECTION 4.02.   Authorization.............................................25

ARTICLE V          ADDITIONAL AGREEMENTS.....................................26

   SECTION 5.01.   Public Announcements......................................26
   SECTION 5.02.   Conveyance Taxes..........................................27
   SECTION 5.03.   Takeover Statutes.........................................27
   SECTION 5.04.   Common Stock and Securities Matters.......................27

ARTICLE VI         CONDITIONS TO THE MERGER..................................30

   SECTION 6.01.   Conditions to Obligation of Each Party to Effect
                   the Merger................................................30
   SECTION 6.02.   Additional Conditions to Obligations of Parent and
                   Merger Sub................................................31
   SECTION 6.03.   Additional Conditions to Obligation of the Company........32

ARTICLE VII        INDEMNIFICATION...........................................33

   SECTION 7.01.   Survival of Representations and Warranties................33
   SECTION 7.02.   Indemnification by the Shareholders and the Company.......33
   SECTION 7.03.   Indemnification by Parent and Merger Sub..................34
   SECTION 7.04.   Procedure of Indemnification..............................34

ARTICLE VIII       GENERAL PROVISIONS........................................36

   SECTION 8.01.   Effectiveness of Representations, Warranties and
                   Agreements................................................36
   SECTION 8.02.   Notices...................................................36
   SECTION 8.03.   Certain Definitions.......................................37

                                       ii
<PAGE>

   SECTION 8.04.   Amendment.................................................38
   SECTION 8.05.   Waiver....................................................38
   SECTION 8.06.   Headings..................................................38
   SECTION 8.07.   Severability..............................................38
   SECTION 8.08.   Entire Agreement..........................................39
   SECTION 8.09.   Assignment................................................39
   SECTION 8.10.   Parties in Interest.......................................39
   SECTION 8.11.   Failure or Indulgence Not Waiver; Remedies Cumulative.....39
   SECTION 8.12.   Governing Law; Jurisdiction...............................39
   SECTION 8.13.   Counterparts..............................................40
   SECTION 8.14.   WAIVER OF JURY TRIAL......................................40
   SECTION 8.15.   Performance of Obligations................................40

                                       iii

<PAGE>

                          AGREEMENT AND PLAN OF MERGER

     AGREEMENT AND PLAN OF MERGER, dated as of January 6, 2006 (this
"Agreement"), among iVoice, Inc., a New Jersey corporation ("Parent"), Thomas
Pharmaceuticals, Ltd. (f/k/a iVoice Acquisition Corp.), a New Jersey corporation
and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Thomas
Pharmaceuticals Ltd., a New York corporation (the "Company"), Farris M. Thomas,
Jr., a natural person residing at 320 West 22nd Street, New York, New York,
10011 ("Thomas"), John E. Lucas, a natural person residing at 1255 North
Gulfstream Avenue, Apartment 703, Sarasota, Florida, 34236 ("Lucas", and
together with Thomas, the "Major Shareholders"), Richard C. Brogle, a natural
person residing at 8 Kenneth Lane, Upper Montclair, New Jersey, 07043, Nina
Schwalbe, a natural person residing at 55 White Street, New York, New York,
10013, John H. Kirkwood, a natural person residing at 2030 Union Street, San
Francisco, California, 94123, and Maureen Gillespie, a natural person residing
at 32 West 31st Street, Studio 7, New York, New York, 10001 (Richard C. Brogle,
Nina Schwalbe, John Kirkwood, Maureen Gillespie, Thomas and Lucas are each
individually referred to herein as "Shareholder" and collectively as the
"Shareholders").

                              W I T N E S S E T H:

     WHEREAS, the Boards of Directors of Parent, Merger Sub and the Company have
each determined that it is advisable and in the best interests of their
respective stockholders, and consistent with and in furtherance of their
respective business strategies and goals, and the Shareholders and Parent, as
the sole stockholder of Merger Sub, have determined it to be in their respective
interests for (i) the Company to merge with and into the Merger Sub upon the
terms and subject to the conditions set forth herein (the "Merger"), (ii) Parent
to purchase three hundred twenty five (325) shares of Series B Preferred Stock,
no par value (the "Series B Preferred Stock"), of the Merger Sub for an
aggregate of Three Hundred Twenty Five Thousand Dollars ($325,000) and for
Parent to purchase a Convertible Debenture of the Surviving Corporation in the
form attached hereto as Exhibit A (the "Debenture") with a principal amount of
Three Hundred Sixty Thousand Dollars ($360,000), in each case, immediately prior
to the Merger, (iii) the Shares (as defined herein) to be converted into Series
A Preferred Stock (as defined herein) in the Merger, (iv) the Major Shareholders
to execute and deliver to the Surviving Corporation each of the Employment
Agreements and all of the Shareholders to execute and deliver the Shareholders'
Agreement (as each is defined herein, and collectively, with the Debenture, this
Agreement, the Registration Rights Agreement, the Administrative Services
Agreement, the Security Agreement, the Escrow Agreement, the Administrative
Services Debenture, the Shareholders' Agreement (the "Transaction Documents")
and (v) the Shareholders, Parent, Merger Sub and the Company consummate each of
the other transaction described herein, as applicable;

     WHEREAS, in furtherance of such combination, the Boards of Directors of
Parent, Merger Sub and the Company and the Shareholders and Parent have each
approved the merger (the "Merger") of the Company with and into the Merger Sub
in accordance with the applicable provisions of the New Jersey Business
Corporations Act (the "BCA") and the Business Corporation Law of the State of
New York (the "BCL") and upon the terms and subject to the conditions set forth
herein; and

<PAGE>

     WHEREAS, pursuant to the Merger, each outstanding share (a "Share") of the
Company's common stock, par value $0.01 per share (the "Company Common Stock"),
shall be converted into the right to receive one share of Series A Preferred
Stock of the Surviving Corporation, no par value per share (the "Series A
Preferred Stock"), per share, deliverable to the holders thereof, upon the terms
and subject to the conditions set forth herein (the "Merger Consideration");

     NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
and agreements herein contained, and intending to be legally bound hereby,
Parent, Merger Sub, the Shareholders and the Company hereby agree as follows:

                                    ARTICLE I

                                   THE MERGER

     SECTION 1.01. The Merger. (a) At the Effective Time (as defined in Section
1.02), and subject to and upon the terms and conditions of this Agreement, and
the BCA and BCL, the Company shall be merged with and into Merger Sub, the
separate corporate existence of the Company shall cease and Merger Sub shall
continue as the surviving corporation under the name "Thomas Pharmaceuticals,
Inc.". Merger Sub as the surviving corporation after the Merger is hereinafter
sometimes referred to as the "Surviving Corporation."

     SECTION 1.02. Effective Time. Concurrently with the execution of this
Agreement, a closing (the "Closing") shall be held at the offices of Kramer
Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New York, New York,
10036, unless another time or place is agreed to in writing by the parties
hereto, for the purpose of confirming the satisfaction or waiver, as the case
may be, of the conditions set forth in Article VI. At the Closing, the parties
hereto shall cause the Merger to be consummated by filing certificates of merger
as contemplated by the BCA and BCL (the "Certificates of Merger"), together with
any required related certificates, with the Secretary of State of the State of
New York and the Secretary of State of the State of New Jersey, in such form as
is required by, and executed in accordance with, the relevant provisions of the
BCA and BCL, as applicable. The Merger shall become effective as of the date and
at the time of such filing, or at such later date and time as may be agreed to
by each of the parties hereto in writing (which will be as soon as reasonably
practicable), specified in the Certificate of Merger filed with the Secretary of
State of the State of New Jersey (the "Closing Date" and the "Effective Time,"
respectively).

     SECTION 1.03. Effect of the Merger. At the Effective Time, the effect of
the Merger shall be as provided in this Agreement, the Certificate of Merger and
the applicable provisions of the BCA and BCL. Without limiting the generality of
the foregoing, and subject thereto, at the Effective Time all the property,
rights, privileges, powers and franchises of the Company and Merger Sub shall
vest in the Surviving Corporation, and all debts, liabilities and duties of the
Company and Merger Sub shall become the debts, liabilities and duties of the
Surviving Corporation.

                                        2
<PAGE>

     SECTION 1.04. Certificate of Incorporation; By-laws.

     (a) Certificate of Incorporation. Subject to the provisions of Section
5.05(a) at the Effective Time the Certificate of Incorporation (including the
Certificates of Designation for the Series A Preferred Stock and the Series B
Preferred Stock) in the form attached as Exhibit B hereto, shall be the
Certificate of Incorporation of the Surviving Corporation until thereafter
amended as provided by the BCA and such Certificate of Incorporation; provided,
however, that the parties hereto hereby agree to use their commercially
reasonable efforts to promptly amend the Certificate of Incorporation of the
Surviving Corporation to provide for two classes of Common Stock, consisting of
Class A Common Stock and Class B Common Stock, with 10,000,000,000 authorized
shares of Class A Common Stock and 50,000 authorized shares of Class B Common
Stock.

     (b) By-laws. Subject to the provisions of Section 5.05(a), at the Effective
Time the By-laws of Merger Sub, as in effect immediately prior to the Effective
Time, shall be the By-laws of the Surviving Corporation until thereafter amended
as provided by the BCA, the Certificate of Incorporation of the Surviving
Corporation and such By-laws.

     SECTION 1.05. Directors and Officers. The initial directors of the
Surviving Corporation, immediately effective upon the Merger, shall be Jerome
Mahoney, Frank Esser and Lucas, each to hold office in accordance with the
Certificate of Incorporation and By-laws of the Surviving Corporation, until
their respective successors are duly elected or appointed and qualified or until
their earlier death, resignation or removal in accordance with the Certificate
of Incorporation, the Certificate of Designation for the Series A Preferred
Stock and Bylaws of the Surviving Corporation. The officers of the Company
immediately prior to the Effective Time shall be Lucas as Chief Executive
Officer and Thomas as President, the initial officers of the Surviving
Corporation, until their respective successors are duly appointed and qualified
or until their earlier death, resignation or removal in accordance with the
Employment Agreement between Thomas and the Surviving Corporation, to be dated
as of the Effective Date and in the form attached as Exhibit C to this Agreement
(the "Thomas Employment Agreement") or the Employment Agreement between Lucas
and the Surviving Corporation, to be dated as of the Effective Date and in the
form attached as Exhibit D to this Agreement (the "Lucas Employment Agreement"
and together with the Thomas Employment Agreement, the "Employment Agreements"),
as applicable, the Certificate of Incorporation and Bylaws of the Surviving
Corporation.

     SECTION 1.06. Conversion of Shares. At the Effective Time, by virtue of the
Merger and without any action on the part of Merger Sub, the Company or the
holder of any of the securities specified below:

     (a) Each Share issued and outstanding immediately prior to the Effective
Time shall be converted into the right to receive one share of Series A
Preferred Stock, deliverable to the holder thereof upon surrender of the
certificate representing such Share in accordance with Section 1.07 hereof. From
and after the Effective Time, the holders of certificates evidencing ownership
of Shares outstanding immediately prior to the Effective Time shall cease to
have any rights with respect to such Shares except as otherwise provided for
herein or by applicable law. No other shares of Series A Preferred Stock shall
be issued or outstanding as of the Effective Time.

                                        3
<PAGE>

     (b) Each issued and outstanding share of Common Stock of Merger Sub, no par
value per share (the "Merger Sub Common Stock"), shall, at the Effective Time,
constitute one validly issued, fully paid and non-assessable share of common
stock, no par value, of the Surviving Corporation (the "Surviving Company Common
Stock"). Immediately prior to the Effective Time, Parent will hold 100% of the
Merger Sub Common Stock. No other shares of Surviving Company Common Stock shall
be issued in connection with the Merger.

     (c) Each issued and outstanding share of Series B Preferred Stock of Merger
Sub of Merger Sub, no par value per share (the "Merger Sub Series B Preferred
Stock"), shall, at the Effective Time, constitute one validly issued, fully paid
and non-assessable share of common stock, no par value, of the Surviving
Corporation (the "Surviving Company Series B Preferred Stock"). Immediately
prior to the Effective Time, Parent will hold 100% of the Merger Sub Series B
Preferred Stock. No other shares of Surviving Company Series B Preferred Stock
shall be issued in connection with the Merger, although other shares of
Surviving Company Series B Preferred Stock shall be issued pursuant to this
Agreement and such further issuances are hereby irrevocably consented to by
Parent and each Shareholder, which consent need not be effected by any future
act by Parent or such Shareholders.

     SECTION 1.07. Delivery by Shareholders of the Shares at Closing.

     (a) On the Closing Date, the Shareholders (in the numbers set out below)
will surrender certificates representing all of their respective Shares to the
Surviving Corporation. Such Shares represent all of the issued and outstanding
shares of capital stock of the Company. The Shares are allocated among the
Shareholders in the following fashion:

          Name                                            No. of Shares

          Farris M. Thomas, Jr.                                 381,568

          John Lucas                                            104,850

          Richard C. Brogle                                       1,000

          Nina Schwalbe                                           1,000

          John Kirkwood                                          11,082

          Maureen Gillespie                                         500

     Immediately following the Effective Time, upon receipt of the certificates
representing the Shares, the Surviving Corporation shall issue to the holders of
such surrendered certificates new certificates of the Surviving Corporation
evidencing an equivalent number of shares of Series A Preferred Stock.

     SECTION 1.08. No Further Ownership Rights in Company Common Stock. The
500,000 shares of Series A Preferred Stock to be delivered in the aggregate upon
the surrender for exchange of Shares in accordance with the terms hereof shall
be deemed to have been issued in full satisfaction of all rights pertaining to
such Shares, and there shall be no further registration

                                        4
<PAGE>

of transfers on the records of the Surviving Corporation of Shares which were
outstanding immediately prior to the Effective Time.

     SECTION 1.09. Taking of Necessary Action; Further Action. Each of Parent,
Merger Sub and the Company will take all such reasonable and lawful actions in
connection with the Closing as may be necessary or appropriate in order to
effectuate the Merger and the other transactions contemplated by this Agreement
in accordance with this Agreement as promptly as possible, upon the terms and
subject to the conditions hereof. If, at any time after the Effective Time, any
such further action is necessary or desirable to carry out the purposes of this
Agreement and to vest the Surviving Corporation with full right, title and
possession to all assets, property, rights, privileges, powers and franchises of
the Company and Merger Sub, the officers and directors of the Company and Merger
Sub immediately prior to the Effective Time are fully authorized in the name of
their respective corporations or otherwise to take, and will take, all such
lawful and necessary action.

     SECTION 1.10. Material Adverse Effect.

     (a) When used in connection with the Company or Merger Sub, as the case may
be, the term "Material Adverse Effect" means any change, effect or circumstance
that is or is reasonably likely to be materially adverse to the business, assets
(including intangible assets), financial condition, prospects or results of
operations, taken as a whole, of the Company or Parent, as the case may be.

     (b) The failure of a representation or warranty to be true and correct,
either individually or together with the failure of other representations or
warranties to be true and correct, or the failure to perform an obligation,
agreement or covenant shall be deemed to have a Material Adverse Effect if (x)
the business, assets (including intangible assets), financial condition, or
results of operations, of the Company or Merger Sub, as the case may be, are or
are reasonably likely to be materially worse than if such representation or
warranty had been true and correct or such obligation, agreement or covenant had
been performed, (y) in the case of the Company, such representation or warranty
materially misstates the capitalization of the Company or the capitalization of
its subsidiaries taken as a whole or (z) the failure of such representation or
warranty to be true and correct or the failure to perform such obligation,
agreement or covenant materially and adversely affects the ability of the
Company or Merger Sub, as the case may be, to consummate the transactions
substantially as contemplated by this Agreement.

                                   ARTICLE II

       REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS AND THE COMPANY

     The Company and the Major Shareholders hereby represent and warrant to
Parent and Merger Sub, on a joint and several basis, as follows:

     SECTION 2.01. Organization and Qualification; Subsidiaries. The Company is
an entity duly organized, validly existing and in good standing under the laws
of the jurisdiction

                                        5
<PAGE>

of its incorporation and has the requisite corporate or other power and
authority necessary to own, lease and operate the properties it purports to own,
operate or lease and to carry on its business as it is now being conducted or is
proposed to be conducted. The Company is duly qualified or licensed as a foreign
corporation to do business, and is in good standing, in each jurisdiction where
the character of the properties owned, leased or operated by it or the nature of
its activities makes such qualification or licensing necessary. The Company does
not have any subsidiaries. The Company does not own any equity or similar
interest in, or any interest convertible into or exchangeable or exercisable for
any equity or similar interest in, any corporation, partnership, joint venture
or other business association or entity.

     SECTION 2.02. Certificate of Incorporation and By-laws. The Company has
heretofore made available to Parent and Merger Sub complete and correct copies
of its Certificate of Incorporation and By-laws, each as amended to date (the
"Company Charter Documents"). All such Company Charter Documents are in full
force and effect. The Company is not in violation of any provision of any
Company Charter Document.

     SECTION 2.03. Capitalization. The authorized capital stock of the Company
consists of 2,000,000 shares of Company Common Stock. As of the date hereof and
the Closing Date, (i) 500,000 shares of Company Common Stock were issued and
outstanding, all of which are validly issued, fully paid and nonassessable, and
(ii) no shares of Company Common Stock were held in treasury. Except for the
500,000 shares held by the Shareholders as listed in Section 1.07(a) of this
Agreement, no other shares of capital stock of the Company, or rights to acquire
such shares, are outstanding as of the Effective Time. There are no options,
warrants or other rights, agreements, arrangements or commitments of any
character binding on the Company relating to the issued or unissued capital
stock of, or other equity interests in, the Company or obligating the Company to
issue or sell any shares of capital stock of, or other equity interests in, the
Company. There are no obligations, contingent or otherwise, of the Company to
repurchase, redeem or otherwise acquire any shares of Company Common Stock.
There are no obligations, contingent or otherwise, of the Company to make any
investment (in the form of a loan, capital contribution or otherwise) in any
other entity. All of the outstanding shares of the capital stock of the Company
are duly authorized, validly issued, fully paid and nonassessable, and all such
shares, or other equity interests, are owned by the Shareholders as listed in
Section 1.07(a) of this Agreement, free and clear of all security interests,
liens, claims, pledges, agreements, charges or other encumbrances of any nature
whatsoever ("Liens"), including, without limitation, any limitations in the
Company's voting rights.

     SECTION 2.04. Authority Relative to this Agreement. The Company has all
necessary corporate power and authority to execute and deliver this Agreement.
The execution and delivery of this Agreement by the Company and the consummation
by the Company of the transactions contemplated hereby have been duly and
validly authorized by all necessary corporate action, and no other corporate
proceedings on the part of the Company are necessary to authorize this Agreement
or to consummate the transactions so contemplated, including the approval of the
Merger and the adoption of this Agreement by the Company's shareholders in
accordance with the BCA and BCL and the filing and recording of appropriate
merger documents consistent with this Agreement as required by the BCA and BCL).
As of the date hereof, the Board of Directors of the Company has declared that
it is advisable and in the best interests of the Company's shareholders for the
Company to enter into this Agreement and to

                                        6
<PAGE>

consummate the Merger upon the terms and subject to the conditions of this
Agreement. This Agreement has been duly and validly executed and delivered by
the Company and, assuming the due authorization, execution and delivery by
Parent, Merger Sub and the Shareholders of this Agreement, constitutes a legal,
valid and binding obligation of the Company and Shareholders.

     SECTION 2.05. Material Contracts; No Conflict; Required Filings and
Consents.

     (a) Section 2.05 of the Company Disclosure Schedule sets forth a complete
and accurate list of each contract to which the Company is a party, or by which
the Company or any of its assets are bound, of the type described below
(collectively, "Material Contracts"), and the Company has delivered to Parent or
made available to Parent for its review true and complete copies of or, if such
contracts are oral, complete and accurate descriptions of the terms of: (i) each
contract that involves the performance of services or the delivery of goods or
materials by Company of an amount or value in excess of Five Thousand Dollars
($5,000); (ii) each contract that involves the performance of services or the
delivery of goods or materials to Company of an amount or value in excess of
Five Thousand Dollars ($5,000); (iii) each contract that was not entered into in
the ordinary course of business and that involves expenditures or receipts of
Company in excess of Five Thousand Dollars ($5,000); (iv) each licensing
agreement (whether as licensor or licensee) or other contract relating to any
Intellectual Property (as defined herein) owned, licensed or used by Company of
an amount or value in excess of Five Thousand Dollars ($5,000); (v) each lease
of real property; (vi) each contract relating to the lending or borrowing of
money, including loan agreements, guarantees of obligations of affiliates and
other persons, performance bonds, letters of credit, and similar instruments or
arrangements, and any security agreement, factoring agreement or other agreement
pursuant to which any Lien is created as security for the obligations with
respect to any such borrowed money; (vii) each contract with any supplier,
distributor, sales representative, dealer or OEM of an amount or value in excess
of Five Thousand Dollars ($5,000); (viii) each contract with or for the benefit
of any current or former officer or director, holder of any security, employee
or consultant of the Company under which the Company has any obligations as of
the date hereof and that (A) involves the making of any payments of an amount in
excess of Five Thousand Dollars ($5,000), (B) contains non-competition
provisions imposing restrictions on the Company or a senior executive officer or
key employee of the Company, or (C) involves any severance or termination
payments or other similar obligation; (ix) any contract with any labor union or
association representing any employee of the Company; (x) any contract relating
to the acquisition by the Company of any operating business or the capital stock
of any other Person; (xi) any contract requiring the payment to any Person of a
brokerage or sale commission or a finder's or referral fee; (xii) any lease,
sublease or other agreement under which the Company is lessor or lessee of any
equipment or other tangible property; (xiii) any contract with a change of
control provision or otherwise requiring any consent, approval, waiver or other
action by any person in connection with the Merger; (xiv) any contract between
or among the Company and any Shareholder or any affiliate of any Shareholder and
(xv) all other contracts, agreements, commitments or other understandings or
arrangements to which the Company is a party or by which it or any of its
properties or assets are bound or affected.

     (b) The execution and delivery of this Agreement by the Company does not,
and the performance of this Agreement by the Company will not (i) conflict with
or violate the Company's Charter Documents, (ii) conflict with or violate any
law, rule, regulation, order,

                                        7
<PAGE>

judgment or decree applicable to the Company or by which any of its properties
is bound or affected or (iii) result in any breach of, or constitute a default
(or an event that with notice or lapse of time or both would become a default)
or impair the Company's rights or alter the rights or obligations of any third
party under, or give to others any rights of termination, amendment,
acceleration or cancellation of, or result in the creation of a lien or
encumbrance on (including a right to purchase) any of the properties or assets
of the Company pursuant to any Material Contract.

     (c) The execution and delivery of this Agreement by the Company does not,
and the performance of this Agreement by the Company will not, require any
consent, approval, authorization or permit of, or filing with or notification
to, any United States or foreign governmental or regulatory authority (each, a
"Governmental Authority") on the part of the Company or any Shareholder.

     SECTION 2.06. Compliance; Permits.

     (a) The Company is not, nor has it at any time been in conflict with, or in
default or violation of, (i) any law, rule, regulation, order, judgment or
decree applicable to the Company or by which any of its properties is bound or
affected or (ii) any note, bond, mortgage, indenture, contract, agreement,
lease, license, permit, franchise or other instrument or obligation to which the
Company is a party or by which the Company or any of its respective properties
is bound or affected, except for any such conflicts, defaults or violations
which would not, individually or in the aggregate, have a Material Adverse
Effect.

     (b) The Company holds all permits, licenses, easements, variances,
exemptions, consents, certificates, orders and approvals from Governmental
Authorities which are material to the operation of the business of the Company,
as it is now being conducted (collectively, the "Company Permits"). The Company
is in compliance with the terms of the Company Permits.

     SECTION 2.07. Financial Statements. Attached as Section 2.07 of the Company
Disclosure Schedule are (i) the unaudited consolidated balance sheet of the
Company as of November 30, 2005 (the "Balance Sheet"), (ii) the unaudited
consolidated balance sheets of the Company as of December 31, 2004 and (iii) and
the related consolidated statements of profit and loss from inception through
(July 24, 2004) through December 31, 2004, as compiled by the Company's
independent public accountants (collectively, the "Financial Statements"). Each
of the Financial Statements (including, in each case, the related notes thereto)
was prepared in accordance with the books and records of the Company and in
accordance with accounting principles generally accepted in the United States
("GAAP") applied on a consistent basis throughout the periods involved (except
as may be indicated therein or in the notes thereto) and fairly presents in all
material respects the consolidated financial position of the Company as at the
respective dates thereof and the consolidated results of its operations for the
periods indicated consistent with the books and records of the Company, except
that Financial Statements are subject to normal and recurring year-end
adjustments which will not be material in amount and such Financial Statements
may not contain all notes required by GAAP.

                                        8
<PAGE>

     SECTION 2.08. Absence of Certain Changes or Events; Company Actions.

     (a) Since the date of the Balance Sheet, the Company has conducted its
business in the ordinary course consistent with past practice and there has not
been: (i) any change, effect or circumstance constituting, individually or in
the aggregate, a Material Adverse Effect; (ii) any damage to, destruction or
loss of any material assets of the Company (whether or not covered by
insurance); (iii) any revaluation by the Company of any of its assets,
including, without limitation, writing down the value of capitalized software or
inventory or writing off notes or accounts receivable, other than, in each case,
in the ordinary course of business; (iv) any transaction, commitment, contract
or agreement entered into by the Company, or any relinquishment by the Company
of any contract or other right, in any case having a value of or involving
aggregate payments or value in excess of $5,000 other than in the ordinary
course of business; or (v) any material adverse change in any customer,
supplier, licensee or licensor relationship, including any cancellation,
termination or adverse modification or, to the knowledge of the Company,
threatened cancellation, termination or adverse modification of any such
relationship. Furthermore, since the date of the Balance Sheet, the Company has
not: (i) issued any notes, bonds or other debt securities or any capital stock
or other equity securities or any securities or rights convertible, exchangeable
or exercisable into any capital stock or other equity securities; (ii) borrowed
any amount or incurred or become subject to any material liabilities, except
current liabilities incurred in the ordinary course of business consistent with
past practice; (iii) discharged or satisfied any material lien or paid any
material obligation or liability, other than current liabilities paid in the
ordinary course of business; (iv) declared, set aside or made any payment or
distribution of cash (including tax distributions) or other property to any of
its respective stockholders with respect to such stockholder's capital stock or
otherwise or purchased, redeemed or otherwise acquired any shares of its capital
stock or other equity securities (including any warrants, options or other
rights to acquire its capital stock or other equity securities); (v) mortgaged
or pledged any of its properties or assets or subjected them to any Lien; (vi)
sold, assigned, transferred, leased, licensed or otherwise encumbered any of its
tangible assets, except in the ordinary course of business consistent with past
practice, or canceled any material debts or claims; (vii) sold, assigned,
transferred, leased, exclusively licensed or otherwise encumbered any
Intellectual Property, disclosed any proprietary trade secrets or other
confidential information to any Person, or abandoned or permitted to lapse any
Intellectual Property; (viii) (A) entered into employment agreements with any
employee (other than an agreement terminable without any fiscal liability) or
made or granted any bonus or any wage or salary increase to any employee or
group of employees other than in the ordinary course of business consistent with
past practice, or (B) made or granted any increase in any employee benefit plan
or arrangement, or amended or terminated any existing employee benefit plan or
arrangement or adopted any new employee benefit plan or arrangement; (ix) made
capital expenditures or commitments therefore other than in the ordinary course
of business and in accordance with the Company's existing capital budget; (x)
made any loans or advances to, guarantees for the benefit of, or any investments
in, any Person other than in the ordinary course of business consistent with
past practice; (xi) made any charitable contributions or pledges or made any
political contributions; (xii) other than in the ordinary course of business,
entered into any agreement or arrangement prohibiting or restricting it from
freely engaging or otherwise restricting the conduct of its business consistent
with past practice; (xiii) amended its certificate of incorporation, bylaws or
similar organizational documents; or (xiv) agreed, whether orally or in writing,
to do any of the foregoing.

                                        9
<PAGE>

     SECTION 2.09. No Undisclosed Liabilities. The Company has no liabilities
(absolute, accrued, contingent or otherwise), whether or not required to be
disclosed in financial statements, including the notes thereto, prepared in
accordance with GAAP, except liabilities (i) provided for in the Balance Sheet,
(ii) incurred since the date of the Balance Sheet in the ordinary course of
business and consistent with past practice and that would not reasonably be
expected to have a Company Material Adverse Effect, (iii) contractual and
service obligations arising in the ordinary course of business (other than
obligations arising out of a material default or alleged material default), (iv)
set forth in Section 2.09 of the Company Disclosure Schedule or (v) not required
to be disclosed in financial statements, including the notes thereto, prepared
in accordance with GAAP, that are immaterial in amount.

     SECTION 2.10. Absence of Litigation. There are no claims, actions, suits,
proceedings or investigations ("Proceedings") pending or, to the best knowledge
of the Company, threatened against the Company or any properties or rights of
the Company before any court, arbitrator or administrative body or Governmental
Authority.

     SECTION 2.11. Employee Benefit Plans; Employment Agreements.

     (a) The Company does not have, and has never had, any (i) "Pension Plans"
(as defined in Section 3(2) of the United States Employee Retirement Income
Security Act of 1974, as amended ("ERISA")), (ii) employee welfare benefit plans
(as defined in Section 3(1) of ERISA), or (iii) any other bonus, stock option,
stock purchase, incentive, deferred compensation, supplemental retirement,
severance and other similar fringe or employee benefit plans, policies,
programs, agreements or arrangements (including those which contain change of
control or pending change of control or similar provisions), written or
otherwise, for the benefit of, or relating to, any former or current employee,
officer, director or consultant (or any of their beneficiaries) of the Company
or any other agreement under which the Company could incur liability under
Section 4980B of the Code or Part 6 of Subtitle B of Title I of ERISA
(hereinafter, "COBRA"), Title IV of ERISA or Section 412 of the Code (together,
for the purposes of this Section 2.11, the "Company Employee Plans").

     SECTION 2.12. Employment and Labor Matters.

     (a) No employee or former employee of the Company is owed any wages,
benefits or other compensation for past services (other than wages, benefits and
compensation accrued in the ordinary course of business during the current pay
period and accrued vacation).

     (b) There are no labor disputes, including, without limitation, charges of
unfair labor practices within the meaning of the National Labor Relations Act,
pending or, to the knowledge of the Company, threatened against the Company .
The Company has never engaged in any unfair labor practices within the meaning
of the National Labor Relations Act. The Company has never been a party to,
bound by, or entered into the process of negotiating any collective bargaining
agreement or union contract. No organizing activities are presently being made
or, to the knowledge of the Company, are anticipated by or on behalf of any
labor union with respect to any employees of the Company. There are no strikes,
slowdowns, work stoppages, picketing or lockouts pending or, to the knowledge of
the Company, threatened, by or with respect to any employees of the Company, and
there has never been any such strikes,

                                       10
<PAGE>

slowdowns, work stoppages, picketing or lockouts. The Company is in material
compliance with all applicable laws relating to employment and employment
practices, workers' compensation, terms and conditions of employment, worker
safety, wages and hours and the Worker Adjustment and Retraining Notification
Act. There has never been any harassment, discrimination, retaliatory act or
similar claim against any officer, director or employee of the Company at any
time.

     SECTION 2.13. Restrictions on Business Activities.

     (a) There is no agreement, judgment, injunction, order or decree binding
upon the Company which has or could reasonably be expected to have the effect of
prohibiting or impairing the conduct of business by the Company as currently
conducted by the Company.

     (b) Section 2.13 of the Company Disclosure Schedule sets forth a list of
each sales agent or consultant of the Company or other person or entity with
distribution rights to any product of the Company, together with a description
of: (a) the products which such person or entity has a right to distribute, (b)
the territory in which the person or entity has distribution rights, (c) the
commissions or other fees which may be earned by or paid to such person or
entity in respect of each product in which such person or entity has a
distribution right, and (d) whether such distribution rights are exclusive or
nonexclusive.

     SECTION 2.14. Title to Property. Except as set forth in Section 2.15 of the
Company Disclosure Schedule, the Company has good title to or have valid
leasehold interests in or valid rights under contract to use all of the real
properties and other assets, individually or in the aggregate, material to the
conduct of the business of the Company, taken as a whole, free and clear of all
liens, charges and encumbrances, except liens for taxes not yet due and payable
and such liens or other imperfections of title, if any, as do not materially
detract from the value of or interfere with the present use of the property
affected thereby or which would not, individually or in the aggregate, have a
Material Adverse Effect; and all leases pursuant to which the Company leases
from others any real or personal property, are in good standing, valid and
effective in accordance with their respective terms, and there is not, under any
of such leases, any existing default or event of default (or event which with
notice or lapse of time, or both, would constitute a default), on the part of
the Company or, to the best knowledge of the Company, any third party, except
where the lack of such good standing, validity and effectiveness or the
existence of such default or event of default would not, individually or in the
aggregate, have a Material Adverse Effect.

     SECTION 2.15. Taxes.

     (a) The Company has timely filed, or caused to be timely filed, all Tax
Returns (as hereinafter defined) required to be filed by it. All such Tax
Returns were true, correct and complete in all respects, the Company has paid,
collected or withheld, or caused to be paid, collected or withheld, all amounts
of Taxes (as hereinafter defined) required to be paid, collected or withheld by
it (whether or not shown as payable on such Tax Returns), other then Taxes being
contested in good faith and for which adequate reserves have been established on
the Balance Sheet. There are no claims or assessments pending against the
Company for any alleged deficiency in any Tax, there are no pending or
threatened audits or investigations for or relating to

                                       11
<PAGE>

any liability in respect of any Taxes, and the Company has not been notified of
any proposed Tax claims or assessments against the Company.

     (b) For purposes of this Agreement, the term "Tax" shall mean any United
States or non-United States federal, national, state, provincial, local or other
jurisdictional income, gross receipts, property, sales, use, license, excise,
franchise, employment, payroll, alternative or add-on minimum, ad valorem,
transfer or excise tax, or any other tax, custom, duty, governmental fee or
other like assessment or charge imposed by any Governmental Authority, together
with any interest or penalty imposed thereon. The term "Tax Return" shall mean a
report, return or other information (including any attached schedules or any
amendments to such report, return or other information) required to be supplied
to or filed with a Governmental Authority with respect to any Tax, including an
information return, claim for refund, amended return or declaration or estimated
Tax.

     (c) The Company has not executed any waivers or extensions of any
applicable statute of limitation to asses any Taxes. There are no outstanding
requests by the Company for any extension of time within which to file any Tax
Return or within which to pay any amounts of Taxes shown to be due on any Tax
Returns. To the best knowledge of the Company, there are no liens for amounts of
Taxes on the assets of the Company except for statutory liens for current Taxes
not yet due and payable. The Company is neither liable for Taxes of any other
person, nor is currently under any contractual obligation to indemnify any
person with respect to Taxes (except for customary agreements to indemnify
lessors, lenders or security holders pursuant to agreements disclosed elsewhere
in the Company Disclosure Schedule), nor is a party to any tax sharing agreement
or any other agreement providing for payments by the Company with respect to
Taxes. Except as set forth in Section 2.15 of the Company Disclosure Schedule,
there are no outstanding powers of attorney enabling any party to represent the
Company with respect to tax matters.

     SECTION 2.16. Environmental Matters.

     (a) The operations and properties of the Company are in compliance with all
Environmental Laws (as hereinafter defined), which compliance includes the
possession by the Company of all permits and governmental authorizations
required under applicable Environmental Laws, and compliance with the terms and
conditions thereof.

     (b) There are no Environmental Claims (as hereinafter defined), pending or,
to the best knowledge of the Company, threatened against the Company or against
any person or entity whose liability for any Environmental Claim the Company has
expressly retained or assumed.

     (c) There are no past or present actions, activities, circumstances,
conditions, events or incidents, including the release, emission, discharge,
presence or disposal of any Materials of Environmental Concern (as hereinafter
defined), that are reasonably likely to form the basis of any Environmental
Claim against the Company or against any person or entity whose liability for
any Environmental Claim the Company has expressly retained or assumed, except
for such Environmental Claims that would not, individually or in the aggregate,
have a Material Adverse Effect.

                                       12
<PAGE>

     (d) To the best knowledge of the Company, (i) there are no off-site
locations where the Company has stored, disposed or arranged for the disposal of
Materials of Environmental Concern which have been listed on the United States
National Priority List (the "National Priorities List") or any state Superfund
site list, and the Company has not been notified or become aware that any of
them may be potentially responsible party at any such location, and (ii) there
are no underground storage tanks located on property owned or leased by the
Company, (iii) there is no material containing friable asbestos contained in or
forming part of any building, building component, structure or office space
owned, leased or operated by the Company and (iv) there are no polychlorinated
biphenyls ("PCBs") or PCB-containing items contained in or forming part of any
building, building component, structure or office space owned, leased or
operated by the Company.

     (e) For purposes of this Agreement:

          (i) "Environmental Claim" means any claim, allegation, accusation,
     action, cause of action, investigation or written notice by any person or
     entity alleging potential liability (including potential liability for
     investigatory costs, cleanup costs, response costs incurred by any
     Governmental Authority or other person, natural resources damages, property
     damages, personal injuries or penalties) arising out of, based on or
     resulting from the presence, or release into the environment, of any
     Material of Environmental Concern at any location, whether or not owned or
     operated by the Company.

          (ii) "Environmental Laws" means all United States and non-United
     States federal, national, state, provincial, local or other jurisdictional
     laws, regulations, codes and ordinances relating to pollution or protection
     of human health and the environment (including ambient air, surface water,
     ground water, land surface or sub-surface strata), including laws and
     regulations relating to emissions, discharges, releases or threatened
     releases of Materials of Environmental Concern, or otherwise relating to
     the manufacture, processing, distribution, use, treatment, storage,
     disposal, transport or handling of Materials of Environmental Concern,
     including, but not limited to, the United States Comprehensive
     Environmental Response Compensation and Liability Act 42 U.S.C. ss. 9601 et
     seq., the United States Resource Conservation and Recovery Act 42 U.S.C.
     ss. 6901 et seq., the United States Toxic Substances Control Act 15 U.S.C.
     ss. 2601 et seq., the United States Occupational Safety and Health Act 29
     U.S.C. ss. 651 et seq., the United States Clean Air Act 42 U.S.C. ss. 7401
     et seq., the United States Clean Water Act 33 U.S.C. ss. 1251 et seq.,
     Proposition 65, as codified in the California Health and Safety Code ss.
     25249.5 et seq., and any other analogous state laws, each as amended or
     supplemented, and any applicable transfer statutes or laws.

          (iii) "Materials of Environmental Concern" means chemicals,
     pollutants, contaminants, hazardous materials, hazardous substances and
     hazardous wastes, medical waste, toxic substances, petroleum and petroleum
     products, asbestos-containing materials, polychlorinated biphenyls, and any
     other chemicals, pollutants or substances regulated under any Environmental
     Law.

     SECTION 2.17. Brokers. No broker, finder or investment banker is entitled
to any brokerage, finder's or other fee or commission in connection with the
transactions

                                       13
<PAGE>

contemplated by this Agreement based upon arrangements made by or on behalf of
the Company or any of the Shareholders.

     SECTION 2.18. Intellectual Property.

     (a) The "Intellectual Property" means all intellectual property owned, used
or licensed (as licensor or licensee) by Company, or that has been used in the
business of Company, or in any product, service, technology or process currently
or formerly offered by Company, or currently under development by Company,
including:

          (i) all domestic and foreign copyright interests in any original work
     of authorship, whether registered or unregistered, including but not
     limited to all copyright registrations or foreign equivalent, all
     applications for registration or foreign equivalent, all moral rights, all
     common-law rights, and all rights to register and obtain renewals and
     extensions of copyright registrations, together with all other copyright
     interests accruing by reason of international copyright convention
     ("Copyrights");

          (ii) all domestic and foreign patents (including certificates of
     invention and other patent equivalents), provisional applications, patent
     applications and patents issuing therefrom as well as any division,
     continuation or continuation in part, reissue, extension, reexamination,
     certification, revival or renewal of any patent, all Inventions (as
     hereinafter defined) and subject matter related to such patents, in any and
     all forms ("Patents");

          (iii) all domestic and foreign trademarks, trade dress, service marks,
     trade names, icons, logos, slogans, and any other indicia of source or
     sponsorship of goods and services, designs and logotypes related to the
     above, in any and all forms, all trademark registrations and applications
     for registration related to such trademarks (including, but not limited to
     intent to use applications), and all goodwill related to the foregoing
     ("Trademarks");

          (iv) all domain name registrations ("Domain Names")

          (v) any formula, design, device or compilation, or other information
     which is used or held for use by a business, which gives the holder thereof
     an advantage or opportunity for advantage over competitors which do not
     have or use the same, and which is not generally known by the public
     ("Trade Secrets"), including, but not limited to, formulas, algorithms,
     market surveys, market research studies, information contained on drawings
     and other documents, and information relating to research, development or
     testing;

          (vi) novel devices, processes, compositions of matter, methods,
     techniques, observations, discoveries, apparatuses, machines, designs,
     expressions, theories and ideas, whether or not patentable ("Inventions");

          (vii) scientific, engineering, mechanical, electrical, financial,
     marketing or practical knowledge or experience useful in the operation of
     Company ("Know How");

                                       14
<PAGE>

          (viii) (A) any and all computer programs and/or software programs
     (including all source code, object code, firmware, programming tools and/or
     documentation), (B) machine readable databases and compilations, including
     any and all data and collections of data, and (C) all content contained on
     Internet site(s) ("Software");

          (ix) all documentation and media constituting, describing or relating
     to the above, including memoranda, manuals, technical specifications and
     other records wherever created throughout the world; and

          (x) the right to sue for past, present, or future infringement and to
     collect and retain all damages and profits related to the foregoing.

     (b) Section 2.18(b) of the Company Disclosure Schedule lists (i) all issued
Patents, and all pending applications for Patents, owned by the Company; (ii)
all registered Trademarks, and all pending applications for Trademarks, owned by
the Company; (iii) all registered Copyrights, and all pending applications for
Copyrights, owned by the Company; and (iv) all Domain Names owned by the
Company.

     (c) Section 2.18(c) of the Company Disclosure Schedule lists all licenses,
sublicenses, agreements or instruments involving the Intellectual Property of
the Company including (i) licenses by the Company to any person of any
Intellectual Property; and (ii) all licenses by any other person to the Company
of any Intellectual Property (except with respect to generally available
"off-the-shelf" software) (each a "License"). Each License identified in Section
2.18(c) of the Company Disclosure Schedule is a valid and binding agreement
enforceable in accordance with its terms. With respect to each License, there is
no material default (or event that with the giving of notice or passage of time
would constitute a material default) by the Company, or to the knowledge of the
Company, the other party thereto. There are no pending and, to the knowledge of
the Company, no threatened claims with respect to any License. Except as
identified on Section 2.18(c) of the Company Disclosure Schedule, no License
contains an indemnity by the Company in favor of a third party with respect to
the Intellectual Property.

     (d) The Company has good and valid title to, or otherwise possesses the
rights to use, all Intellectual Property necessary to permit the Company to
conduct the business and operations of the Company from and after the Closing
Date, in the same manner as it is being conducted as of the date hereof, and to
the knowledge of Company, as currently contemplated to be conducted by the
Company. Neither the consummation of the transactions contemplated by this
Agreement nor the Company's performance hereunder will result in the diminution,
license, transfer, termination or forfeiture of the Company's rights in the
Intellectual Property or Licenses. Except for Intellectual Property owned by
third parties, no person or entity other than the Company has any right or
interest of any kind or nature in or with respect to the Intellectual Property,
or any portion thereof, or any rights to sell, license, lease, transfer or use
or otherwise exploit the Intellectual Property or any portion thereof. All
officers, employees and contractors of the Company who have created Intellectual
Property, have executed an agreement under which all rights, title and ownership
in and to such Intellectual Property have been assigned to the Company.

                                       15
<PAGE>

     (e) Except as disclosed in Section 2.18(e) of the Company Disclosure
Schedule, the Company has not been alleged to have, nor to the knowledge of the
Company, has Company infringed upon, misappropriated or misused any Intellectual
Property or other proprietary information of another person or entity. There are
no pending and, to the knowledge of the Company, threatened claims or claim, and
no action, suit, proceeding or investigation, whether civil, criminal,
administrative or investigative (collectively, "Proceedings") contesting or
challenging the Intellectual Property, or the Company's or any of its
subsidiaries' use of the Intellectual Property owned by another person or
entity. To the knowledge of the Company, no third party including any current or
former employee or contractor of Company, is infringing upon, misappropriating,
or otherwise violating Company's rights to the Intellectual Property.

     (f) Patents:

          (i) All of the issued Patents and pending applications for Patents of
     Company, if any, are currently in compliance with all legal requirements
     (including payment of filing, examination, and maintenance fees), and are
     not subject to any maintenance fees or taxes or actions falling due within
     ninety (90) days after the Effective Time.

          (ii) No Patent of Company has been or is now involved in any
     infringement, interference, reissue or reexamination Proceeding and, to the
     knowledge of Company, no such action is threatened with respect to any of
     the Patents of Company.

          (iii) No product manufactured or sold by Company, nor any Patent of
     Company is alleged to infringe any patent or product of any person, and to
     the knowledge of Company, no Patent of, or product manufactured or sold by,
     Company is infringed.

          (iv) All products sold under the Patents have been marked with the
     proper patent notice.

     (g) Trademarks:

          (i) All registered Trademarks, and pending applications for Trademarks
     with the United States Patent and Trademark Office ("PTO") or any other
     country's trademark office, of Company are currently in compliance with all
     legal requirements (including the filing of affidavits of use and renewal
     applications as applicable), and are not subject to any maintenance fees or
     taxes or actions falling due within ninety (90) days after the Effective
     Time.

          (ii) No Trademark of the Company has been or is now involved in any
     opposition, infringement, dilution, unfair competition or cancellation
     Proceeding and, to the knowledge of the Company, no such action is
     threatened with respect to any of the Trademarks of the Company.

          (iii) No Trademark of the Company is alleged to infringe any trade
     name, trademark or service mark of any other person or entity, and to the
     knowledge of the Company, no Trademark of the Company is infringed.

                                       16
<PAGE>

          (iv) All products displaying a Trademark of the Company or any of its
     subsidiaries which has been registered with the PTO, bear the proper
     federal registration notice.

     (h) Copyrights:

          (i) All registered Copyrights and pending applications for Copyrights
     of the Company are currently in compliance with all legal requirements, and
     are not subject to any maintenance fees or taxes or actions falling due
     within ninety (90) days after the Effective Time.

          (ii) No Copyright of the Company has been or is now the subject of any
     invalidation or infringement Proceeding and, to the knowledge of the
     Company, no such action is threatened with respect to any Copyright of the
     Company.

          (iii) No Copyright of the Company is alleged to infringe any copyright
     of any other person or entity, and to the knowledge of the Company, no
     Copyright of the Company is infringed.

          (iv) All works encompassed by the Copyrights of the Company have been
     marked with the proper copyright notice.

     (i) Domain Names:

          (i) All registered Domain Names of the Company are currently in
     compliance with all legal requirements and are not subject to any
     maintenance fees or taxes or action falling due within ninety (90) days
     after the Effective Time.

          (ii) No Domain Name of the Company has been or is now the subject of
     any dispute resolution or infringement Proceeding and, to the knowledge of
     the Company, no such action is threatened with respect to any Domain Name
     of the Company.

          (iii) No Domain Name of the Company or any of its subsidiaries is
     alleged to infringe the trademark or domain name of any other person or
     entity, and to the knowledge of the Company, no Domain Name of the Company
     is infringed.

     (j) Section 2.18(j) of the Company Disclosure Schedule lists all products
of the Company (alphabetically by product with the aggregate sales receipts for
each product for each calendar year beginning in 2004) distributed or sold by
the Company, listed by category. Section 2.18(j) of the Company Disclosure
Schedule also sets forth, for each product, the following: (i) a list of all
contracts (including all development agreements, Licenses, manufacturer's
representative agreements, distribution or other agreements) relating to the
products; (ii) as to any contracts under which compliance or performance
continues to be required, the advances paid or payable, and the royalties or
other sums payable, to any person or entity with respect to such product and
(iii) a list of persons or entity's with distribution rights to such product
together with a description of: (A) the territory in which the person or entity
has distribution rights; and (B) whether such distribution rights are exclusive
or nonexclusive.

                                       17
<PAGE>

     (k) The Company have taken commercially reasonable steps to protect the
proprietary nature of the Intellectual Property and to maintain in confidence
all Trade Secrets and confidential Intellectual Property and information owned
or used by the Company. Except as set forth in Section 2.18(k) of the Company
Disclosure Schedule, to the knowledge of the Company, no Trade Secret or other
confidential Intellectual Property or information of the Company has been
disclosed or authorized to be disclosed to any person, including any employee,
agent, contractor, or other entity, other than pursuant to a non-disclosure
agreement or other conditional obligation that protects the Company's
proprietary interests in and to such Trade Secrets or confidential Intellectual
Property or information.

     (l) Section 2.18(l) of the Company Disclosure Schedule contains a true and
complete list of all of the Software included, embedded or incorporated in or
developed for inclusion in the Company's products or websites, or used in the
delivery of the Company's services (the "Company Software"). The Company owns
full and unencumbered right and good, valid and marketable title or has valid
licenses to such Company Software, and the Company Software owned by the Company
is free and clear of all Liens. The Company has not incorporated any third party
Intellectual Property into the Company Software not identified in Section
2.18(l) of the Company Disclosure Schedule. Except as identified in Section
2.18(l) of the Company Disclosure Schedule), no open source or public library
software, including any version of any software licensed pursuant to any GNU
public license, is, in whole or in part, embodied or incorporated in the Company
Software.

     (m) The Company employs commercially reasonable measures to ensure that the
Company Software contain no "viruses." For the purposes of this Agreement,
"virus" means any computer code intentionally designed to disrupt, disable or
harm in any manner the operation of any software or hardware. To the knowledge
of the Company, none of the Company Software Programs contains any worm, bomb,
backdoor, clock, timer or other disabling device, code, design or routine which
causes the software to be erased, inoperable, impaired in performance or
otherwise incapable of being used, either automatically or upon command by any
person.

     (n) The Company's Intellectual Property (including, to the knowledge of the
Company, the Intellectual Property of third parties' licensed to the Company),
is free and clear of any and all Liens.

     (o) Section 2.18(o) of the Company Disclosure Schedule sets forth all
agreements by which the Company is obligated to make to third parties any
payments related to the Company Intellectual Property. The Company is not bound
by an agreement by which it owes any present or future royalties or other
payments to third parties in respect of Intellectual Property in excess of
$10,000.

     (p) The Company has implemented industry "best practices" to ensure the
physical and electronic protection of its websites and information assets from
unauthorized disclosure, use or modification. Other than as set forth in Section
2.18(p) of the Company Disclosure Schedule, there has been no breach of security
involving any Company or its subsidiaries websites or information assets. All
data which has been collected, stored, maintained or otherwise used by the
Company have been collected, stored, maintained and used in accordance with all
applicable U.S. and foreign laws, rules, regulations, guidelines and

                                       18
<PAGE>

industry standards. The Company have not received, and to the knowledge of the
Company, will not be receiving, any oral or written notice of noncompliance with
applicable data protection laws, rules, regulations, guidelines or industry
standards.

     (q) Except as disclosed in Section 2.18(q) of the Company Disclosure
Schedule, all products of the Company, and all Company Software, conform to the
descriptions of, and perform in accordance with, any warranties, representations
or descriptions regarding the products or the Company Software made by the
Company, including any warranties, representations or descriptions contained in
any applicable License or documentation, and the Company have not received any
notice that any product of the Company, or any Company Software, does not so
perform or conform.

     SECTION 2.19. Certain Business Practices. The Company has not (i) used any
funds for unlawful contributions, gifts, entertainment or other unlawful
payments related to a political activity or (ii) made any unlawful payment to
any foreign or domestic government official or employee or to any foreign or
domestic political party or campaign or violated any provision of the Foreign
Corrupt Practices Act of 1977, as amended.

     SECTION 2.20. No Bankruptcy. No order has been made or petition presented
for the winding up, insolvency, liquidation or bankruptcy of the Company, nor is
there any reasonable basis for any such order or unsatisfied judgment or court
order against the Company.

     SECTION 2.21. Title to Properties; Absence of Encumbrances. The Company has
good and valid title to or, in the case of leased property, valid and subsisting
leasehold interests in, all of its properties and assets of whatever kind
(whether real or personal) used or held for use in its business, including,
without limitation, all properties and assets that are shown on the Balance
Sheet (except for assets sold in the ordinary course of business since the date
of such Balance Sheet), which represent all such property and assets that are
used in the conduct of its businesses as presently conducted, in each case free
and clear of any and all Liens, except (i) for those securing Taxes, assessments
and other governmental charges or levies not yet due and payable (excluding any
imposed pursuant to any of the provisions of ERISA), and (ii) such imperfections
in title, liens and easements as do not materially detract from or interfere
with the use of the properties subject thereto or affected thereby or otherwise
impair business operations involving such properties (encumbrances in clauses
(i) and (ii) being "Permitted Encumbrances"). All assets, properties and rights
relating to the Company's business are held by, and all agreements, obligations
and transactions relating to the Company's business have been entered into,
incurred and conducted by, the Company rather than any affiliate, and the
Company does not use any other assets, properties or rights in the conduct of
its business as presently conducted. No person, including without limitation any
Shareholder, has any option, right of first refusal, right of first offer,
preemptive right or any other right of any nature to acquire any material assets
of the Company. The tangible assets of the Company are free from material
defects, have been maintained in accordance with normal industry practice, are
in good operating condition and repair (subject to normal wear and tear) and are
suitable for the purpose for which they are presently used.

     SECTION 2.22. Real and Personal Property. Section 2.22 of the Company
Disclosure Schedule contains a complete and correct list of all real property
(including buildings

                                       19
<PAGE>

and structures) leased or subleased by the Company and all interests therein
(including a street address). The Company does not own and has never owned any
real property. All material work required to be done by the Company under law or
any contract or arrangement to which the Company is subject or a party as
landlord or tenant has been duly performed. No condemnation or other proceeding
is pending or, to the knowledge of the Company, threatened which would affect
the use of any such property by the Company. The Company enjoys peaceful and
undisturbed possession under all real property leases under which it is
operating in accordance with the terms of such leases, and all rents and
additional rents due to date from the Company under such leases have been paid
in full. Section 2.22 of the Company Disclosure Schedule also contains a
complete and correct list of all equipment, machinery, computers, furniture,
leasehold improvements, vehicles and other personal property owned by the
Company with an original cost in excess of $1000 individually. Except as set
forth in Section 2.22 of the Company Disclosure Schedule, none of the Company's
personal property is held under any lease, security agreement, conditional sales
contract or other title retention or security arrangement.

     SECTION 2.23. Transactions with Affiliates; Management Relationships.

     (a) Other than as set forth in Section 2.23 of the Company Disclosure
Schedule, the Company has not, directly or indirectly, engaged in any
transactions or financial or commercial arrangements (i) with any Shareholder of
the Company or (ii) (except for employment arrangements with its employees) with
any officer or director or with any of their respective affiliates or relatives
(each a "Related Party"). The Company has no obligation to or claim against any
Related Party, and no Related Party has any obligation to or claim against the
Company, except for obligations of the Company pursuant to (A) employment
arrangements with its employees, (B) the Company's certificate of incorporation,
(C) the Company's by-laws, and (D) applicable law. Section 2.23 of the Company
Disclosure Schedule describes the nature and extent of any products, services or
benefits provided to the Company by any Related Party without a corresponding
charge equal to the fair market value of such products, services or benefits.

     (b) No executive officer or director of the Company owns any interest in
any property or assets of the Company (except as a stockholder of the Company)
and, to the knowledge of the Company, no executive officer of the Company owns
any interest in (i) any current competitor, customer or supplier of the Company
or (ii) any person that is currently a party to any material contract or
agreement with the Company, other than holdings of less than 1% of a class of a
company's publicly traded securities.

     SECTION 2.24. Insurance. Section 2.24 of the Company Disclosure Schedule
lists all insurance policies owned or held by the Company on the date hereof.
All such policies are in full force and effect, all premiums with respect
thereto have been paid to the extent due, no notice of cancellation or
termination has been received with respect to any such policy and no claim is
currently pending under any such policy involving an amount in excess of $5,000.

     SECTION 2.25. Books and Records.

     (a) The books and records of each of the Company are complete and correct
in all material respects and have been maintained in accordance with sound
business practices.

                                       20
<PAGE>

     (b) The minute books of the Company, which have been previously provided to
Parent, contain complete and accurate records of all meetings in all material
respects and accurately reflect in all material respects all other corporate
action of the stockholders and board of directors of the Company through the
date of this Agreement.

     SECTION 2.26. Accounts Receivable. All accounts receivable of the Company,
whether reflected in the Balance Sheet or otherwise, represent sales actually
made in the ordinary course of business, have been reflected properly in their
books and records and represent valid obligations to the Company.

     SECTION 2.27. Customers and Suppliers. Section 2.27 of the Company
Disclosure Schedule sets forth (a) the ten largest customers of the Company, and
(b) the ten largest suppliers of the Company, in each case on the basis of cost
of goods or services purchased, for the eleven months ended November 30, 2005
(collectively, the "Customers and Suppliers"). The Company knows of no plan or
intention of any of the Customers or Suppliers to terminate, cancel or otherwise
adversely modify in any material respect its relationship with the Company or to
decrease materially or limit any of its products or services to the Company or
its usage or purchase of any of the services or products of the Company. The
Company does not offer or use any current customer incentive programs, whether
written or oral and whether or not deemed or considered to be legally
enforceable, which involve the payment of rebates or issuance of credits by the
Company or the sharing of marketing expenses by the Company.

     SECTION 2.28. Employee Conflicts. To the knowledge of the Company, no
employee of the Company is in violation of any term of any employment contract,
inventions disclosure agreement, confidentiality agreement, non-competition
agreement or restrictive covenant to or with a former employer relating to the
right of any such employee to be employed by the Company because of the nature
of the business conducted or presently proposed to be conducted by the Company
or relating to the use of trade secrets or proprietary information of others.

     SECTION 2.29. Bank Accounts. Schedule 2.29 of the Company Disclosure
Schedule sets forth a complete and correct list of each bank in which the
Company has an account or safe deposit or lockbox, the account or box number, as
the case may be, and the name of every person authorized to draw thereon or
having access thereto.

     SECTION 2.30. No Required Disclosure. The Company is not required to
disclose the existence of this Agreement or any other Transaction Document, the
terms hereof or thereof, or the transactions contemplated hereby or thereby, to
any person (other than to its directors, officers and, to the extent required by
applicable Law, any Shareholder).

     SECTION 2.31. Internal Controls. The Company maintains a system of internal
accounting controls sufficient to provide reasonable assurance that (i)
transactions are executed in accordance with management's general or specific
authorizations; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain
asset accountability; (iii) access to assets is permitted only in accordance
with management's general or specific authorization; and (iv) the recorded
accountability for assets is

                                       21
<PAGE>

compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.

     SECTION 2.32. Inventory. The Company's inventory as set forth in the
Balance Sheet has been valued in accordance with GAAP consistently applied and
consists of items of quality useable and saleable in the normal course of the
Company's business except for items of obsolete materials and materials of below
standard quality, all of which have been written down to realizable market value
or for which adequate reserves have been provided in the Balance Sheet.

     SECTION 2.33. Product Liability. Except as set forth on Section 2.33 of the
Company Disclosure Schedule, the Company has no liability that relates to, or
that arises out of, products manufactured, shipped or sold by or on behalf of
the Company on or prior to the Closing Date (including claims of negligence,
personal injury, product damage, product liability, product warranties,
promotional obligations, strict liability, product recall, safety or regulatory
compliance, infringement of intellectual property or any other similar or
related claims, whether such liability, obligation or commitment relates to or
arises out of accidents, injuries or losses occurring on or prior to or after
the Closing Date).

     SECTION 2.34. True and Complete. No representation or warranty made by the
Company or any Shareholder in this Agreement, nor any statement, certificate or
Exhibit furnished by or on behalf of the Company or the Shareholders pursuant to
this Agreement, nor any document or certificate delivered to Parent or Merger
Sub pursuant to this Agreement, or in connection with the transactions
contemplated hereby, contains or shall contain any untrue statement of a
material fact, or omits or shall omit to state a material fact necessary to make
the statements contained therein not misleading. Neither the Company nor any
Shareholder has failed to disclose to Parent or Merger Sub any pending
developments or circumstances of which it is aware which are reasonably likely
to have a material adverse effect on the business or the Company.

                                   ARTICLE III

             REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

     Parent and Merger Sub hereby, jointly and severally, represent and warrant
to the Company as follows:

     SECTION 3.01. Organization and Qualification; Subsidiaries. Each of Parent
and Merger Sub is an entity duly organized and validly existing under the laws
of the jurisdiction of its incorporation and has the requisite corporate or
other power and authority necessary to own, lease and operate the properties it
purports to own, operate or lease and to carry on its business as it is now
being conducted, except where the failure to be so organized and existing or to
have such power or authority could not reasonably be expected to have a Material
Adverse Effect. Each of Parent and its subsidiaries is duly qualified or
licensed as a foreign corporation to do business, and is in good standing, in
each jurisdiction where the character of its properties owned, leased or
operated by it or the nature of its activities makes such qualification or

                                       22
<PAGE>

licensing necessary, except for such failures to be so duly qualified or
licensed and in good standing that could not reasonably be expected to have a
Material Adverse Effect.

     SECTION 3.02. Capitalization. The authorized capital stock of Merger Sub
consists of one million two hundred thousand (1,200,000) shares of capital
stock, of which two hundred (200) shares are classified as Merger Sub Common
Stock, five hundred thousand (500,000) shares are classified as Series A
Preferred stock, no par value per share ("Merger Sub Series A Preferred Stock"),
and one thousand (1,000) shares are classified as Merger Sub Series B Preferred
Stock. As of the date hereof and the Closing Date, (i) one hundred (100) shares
of Company Common Stock were issued and outstanding, all of which are validly
issued, fully paid and nonassessable, (ii) no shares of Merger Sub Series A
Preferred Stock were issued and outstanding, and (iii) three hundred twenty five
(325) shares of Merger Sub Series B Preferred Stock were issued and outstanding.
Except for (x) the one hundred (100) shares of Merger Sub Common Stock, (y)
three hundred twenty five (325) shares of Merger Sub Series B Preferred Stock
held by Parent and (z) the Debenture issued to Parent in the aggregate principal
amount of Three Hundred Sixty Thousand ($360,000), no other shares of capital
stock of Merger Sub, or rights to acquire such shares, are issued or outstanding
as of the Closing. Except for the Debentures and the Merger Sub Series B
Preferred Stock, and the shares of Merger Sub Common Stock issuable upon the
conversion of such Merger Sub Series B Preferred Stock and the Debenture, an
Administrative Services Debenture in the principal amount of One Hundred
Thousand Dollars ($100,000) to be issued to Parent by the Surviving Corporation
as of the Effective Time (the "Administrative Services Debenture"), and the
other commitments specified in this Agreement or any Transaction Document, there
are no options, warrants or other rights, agreements, arrangements or
commitments of any character binding on the Merger Sub relating to the issued or
unissued capital stock of, or other equity interests in, Merger Sub or
obligating Merger Sub to issue or sell any shares of capital stock of, or other
equity interests in Merger Sub. There are no obligations, contingent or
otherwise, of Merger Sub to repurchase, redeem or otherwise acquire any shares
of Merger Sub Common Stock. All of the outstanding shares of the capital stock
of Merger Sub are duly authorized, validly issued, fully paid and nonassessable,
and all such shares, or other equity interests, are owned by Parent, free and
clear of all Liens, including, without limitation, any limitations in the
Company's voting rights.

     SECTION 3.03. Authority Relative to This Agreement. Each of Parent and
Merger Sub has all necessary corporate power and authority to execute and
deliver this Agreement, as applicable, and to perform its obligations hereunder
and to consummate the transactions contemplated hereby. The execution and
delivery of this Agreement by Parent and Merger Sub and the consummation by
Parent and Merger Sub of the transactions contemplated hereby have been duly and
validly authorized by all necessary corporate action on the part of Parent and
Merger Sub, and no other corporate proceedings on the part of Parent or Merger
Sub are necessary to authorize this Agreement or to consummate the transactions
so contemplated. The Board of Directors of Parent has determined that it is
advisable and in the best interests of Parent's stockholders for Parent to enter
into this Agreement, and for Parent to consummate the Merger upon the terms and
subject to the conditions of this Agreement. The Board of Directors of Merger
Sub has determined that it is advisable and in the best interests of Merger
Sub's sole stockholder, Parent, for Merger Sub to enter into this Agreement, and
for Merger Sub to consummate the Merger upon the terms and subject to the
conditions of this Agreement. This Agreement has been duly and validly executed
and delivered by Parent and Merger Sub, and,

                                       23
<PAGE>

assuming due authorization, execution and delivery by the Company, constitutes
the legal, valid and binding obligation of Parent and Merger Sub.

     SECTION 3.04. No Conflict. The execution and delivery of this Agreement by
Parent and Merger Sub do not, and the performance of this Agreement by Parent
and Merger Sub will not, (i) violate Parent or Merger Sub's certificate of
incorporation or by-laws (or equivalent organizational documents) (ii) conflict
with or violate any law, rule, regulation, order, judgment or decree applicable
to Parent, Merger Sub or any of their subsidiaries or by which any of their
respective properties is bound or affected or (iii) result in any breach of, or
constitute a default (or an event that with notice or lapse of time or both
would become a default) or impair Parent, Merger Sub's or any of their
subsidiaries' rights or alter the rights or obligations of any third party
under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of a lien or encumbrance on
(including a right to purchase) any of the properties or assets of Parent,
Merger Sub or any of their subsidiaries pursuant to, any note, bond, mortgage,
indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation to which Parent, Merger Sub or any of their
subsidiaries is a party or by which Parent, Merger Sub or any of their
subsidiaries or any of their respective properties is bound or affected, except,
in the case of clause (ii) or (iii), for any such conflicts, violations,
breaches, defaults or other occurrences that would, individually or in the
aggregate, have a Material Adverse Effect on either Parent or Merger Sub.

     SECTION 3.05. Authorization and Validity; Issuance of Shares. The shares of
Series A Preferred Stock to be issued in exchange for the Shares at the
Effective Time in connection with the Merger will be validly issued, fully paid
and non-assessable, free and clear of all liens, encumbrances and rights of
first refusal, other than liens and encumbrances created by the Shareholders
will not be subject to any preemptive or similar rights.

     SECTION 3.06. Absence of Litigation. There are no claims, actions, suits,
proceedings or investigations pending or, to the best knowledge of Parent or
Merger Sub, threatened against Parent, Merger Sub or any of their subsidiaries,
or any properties or rights of Parent, Merger Sub or any of their subsidiaries,
before any court, arbitrator or administrative body or Governmental Authority,
that would, individually or in the aggregate, have a material adverse effect on
the ability of Parent and Merger Sub to consummate the transactions contemplated
by this Agreement. Neither Parent nor Merger Sub is subject to any Order of any
Governmental or Regulatory Authority that would, individually or in the
aggregate have a material adverse effect on the ability of Parent and Merger Sub
to consummate the transactions contemplated by this Agreement.

     SECTION 3.07. Ownership of Merger Sub. Merger Sub is a direct, wholly owned
subsidiary of Parent.

     SECTION 3.08. Ownership of Shares. As of the date hereof, neither Parent
nor Merger Sub owns, beneficially or of record, any Shares.

     SECTION 3.09. Other Agreements. Except for this Agreement, the Transaction
Documents and as otherwise set forth on Schedule 3.09 to the Merger Sub
Disclosure Schedule, since its incorporation, Merger Sub has neither engaged in
any substantial business nor entered

                                       24
<PAGE>

into any material agreements, except for this Agreement, the other Transaction
Documents, and documents ancillary to or contemplated by the transactions
described herein and therein.

                                   ARTICLE IV

                           SHAREHOLDER REPRESENTATIVE

     SECTION 4.01. Appointment. In order to administer the transactions
contemplated by this Agreement and the Escrow Agreement, including, without
limitation, the indemnification obligations of the Shareholders under Article
VII, the Shareholders hereby designate and appoint Thomas as their
representative for this Agreement and the Escrow Agreement and as
attorney-in-fact and agent for and on behalf of each Shareholder (in such
capacity, the "Shareholder Representative"). Said power of attorney shall be
coupled with an interest and shall be irrevocable.

     SECTION 4.02. Authorization. Each Shareholder hereby authorizes the
Shareholder Representative to represent each Shareholder, and their successors,
with respect to all matters arising under this Agreement or any other
Transaction Documents, including, without limitation, (i) to take all action
necessary in connection with the indemnification obligations of the Shareholders
under Article VII, including, the defense or settlement of any claims and the
making of payments with respect thereto, (ii) to give and receive all notices
required to be given under this Agreement or any other Transaction Document and
(iii) to take any and all additional action as is contemplated to be taken by or
on behalf of the Shareholders by the Shareholder Representative pursuant to this
Agreement.

     SECTION 4.03. Replacement. In the event that Thomas dies, becomes unable to
perform his responsibilities as Shareholder Representative or resigns from such
position, Lucas shall automatically become the Shareholder Representative. In
the event that, following his appointment as Shareholder Representative, Lucas
dies, becomes unable to perform his responsibilities as Shareholder
Representative or resigns from such position, the Shareholders having an
aggregate of 50% ownership interest in the Company immediately prior to the
Merger (or the respective successors in interest to the Shareholders) shall
select another representative to fill such vacancy and such substituted
Shareholder Representative shall be deemed to be the Shareholder Representative
for all purposes of this Agreement and the Escrow Agreement. Upon any change in
the Shareholder Representative, the Shareholders shall provide written notice to
Parent, Merger Sub and Surviving Corporation shall indicate the identity of the
substitute Shareholder Representative, who shall have agreed to the terms of
this Section as if he or she were a party hereto.

     SECTION 4.04. Powers. All decisions and actions by the Shareholder
Representative, including, without limitation, any agreement between the
Shareholder Representatives and the Parent, Merger Sub or Surviving Corporation
relating to the indemnification obligations of the Shareholders under Section
VII, including, the defense or settlement of any claims and the making of
payments with respect hereto, shall be binding upon all the Shareholders as if
they had taken such action themselves, and no Shareholder shall have the right
to object, dissent, protest or otherwise contest the same. The Shareholder

                                       25
<PAGE>

Representative shall incur no liability to the Shareholders with respect to any
action taken or suffered by the Shareholder Representative in reliance upon any
notice, direction, instruction, consent, statement or other documents believed
by him or her to be genuinely and duly authorized, nor for any other action or
inaction with respect to the indemnification obligations of the Shareholder
under Article VII, including the defense or settlement of any claims and the
making of payments with respect thereto, except to the extent resulting from the
Shareholder Representative's own willful misconduct or negligence. The
Shareholder Representative may, in all questions arising under this Agreement or
any Transaction Document rely on the advice of counsel, and for anything done,
omitted or suffered in good faith by the Shareholder Representative shall not be
liable to the Shareholders.

     SECTION 4.05. Reliance. Parent, Merger Sub and the Surviving Corporation
are hereby authorized to rely conclusively on the actions, instructions and
decisions of the Shareholder Representative with respect to this Agreement and
the Escrow Agreement, including, without limitation, the indemnification
obligations of the Shareholders under Article VII, including the defense or
settlement of any claims or the making of payments by the Shareholder
Representative hereunder, and no party hereunder shall have any cause of action
against Parent, Merger Sub or the Surviving Corporation to the extent such
parties have relied upon the actions, instructions or decisions of the
Shareholder Representative. If the Shareholder Representative undertakes any
action hereunder in his capacity as a Shareholder Representative, the
Shareholder Representative shall be deemed to make a representation to each of
the Company, Parent, Merger Sub, and the Surviving Corporation that the
Shareholder Representative is authorized hereunder to undertake such action. The
Shareholder Representative agrees to indemnify and hold harmless each of the
Company, Parent, the Surviving Corporation and Merger Sub for any Damages
suffered by such party as a result of the reliance by such party on the actions
of the Shareholder Representative hereunder. For the avoidance of doubt, it is
hereby acknowledged that the indemnity obligation under this Section is not
subject to the limitations set forth in Section 7.02.

     SECTION 4.06. Expenses. The Shareholders acknowledge and agree that the
Shareholder Representative may incur costs and expenses on behalf of the
Shareholders in his capacity as Shareholder Representative, including costs and
fees for services of professionals provided to the Shareholder Representative
acting in such capacity. Each of the Shareholders agrees to pay the Shareholder
Representative, promptly upon demand by the Shareholder Representative
therefore, a percentage of any expenses equal to such Shareholder's ownership
interest in the Company immediately prior to the Closing.

                                    ARTICLE V

                              ADDITIONAL AGREEMENTS

     SECTION 5.01. Public Announcements. The initial press release regarding the
Merger shall be a joint press release mutually agreed upon, and thereafter
Parent and the Shareholders will consult with one another before issuing any
press release or otherwise making any public statements with respect to the
transactions contemplated hereby, including the Merger, and shall not issue any
such press release or make any such public statement prior to such consultation,
except as may be required by applicable Law or by obligations pursuant to any

                                       26
<PAGE>

listing agreement with the NASD Over-the-Counter Bulletin Board, as determined
in good faith by such party.

     SECTION 5.02. Conveyance Taxes. Parent, Merger Sub, the Company and the
Surviving Corporation shall each cooperate with the others in the preparation,
execution and filing of all returns, questionnaires, applications or other
documents regarding any real property transfer or gains, sales, use, transfer,
value added, stock transfer and stamp taxes, any transfer, recording,
registration and other fees, and any similar taxes which become payable in
connection with the transactions contemplated hereby that are required or
permitted to be filed on or before the Effective Time, and the Surviving
Corporation shall be responsible for the payment of all such taxes and fees.

     SECTION 5.03. Takeover Statutes. If any limitations on business
combinations contained in any restrictive provision of any "fair price,"
"moratorium," "control share acquisition," "interested stockholder" or other
similar anti-takeover statute or regulation (a "Takeover Statute") is or may
become applicable to the Merger or the other transactions contemplated by this
Agreement, the Company and the board of directors of the Company shall grant all
approvals and use their reasonable best efforts to take all actions as are
necessary so that such transactions may be consummated as promptly as
practicable on the terms contemplated by this Agreement and otherwise act to
eliminate or minimize the effects of such Takeover Statute on such transactions.

     SECTION 5.04. Additional Purchases of Securities by Parent.

     (a) Parent agrees with and covenants to the Shareholders that, following
the Effective Time, it will purchase from the Surviving Corporation, (i) an
additional Debenture in the principal amount of at least Two Hundred Twenty Five
Thousand Dollars ($225,000) on or before April 30, 2006, (ii) an additional two
hundred twenty five (225) shares of Series B Preferred Stock at a cost of Two
Hundred Twenty Five Thousand Dollars ($225,000) on or before April 30, 2006.

     (b) Parent further agrees with and covenants to the Shareholders that if
the Surviving Corporation generates sales (including invoices given in good
faith) of at least One Million Dollars ($1,000,000) in the period beginning on
January 1, 2006 and ending on the close of business on September 30, 2006, then
upon ten (10) days' written notice from the Shareholder Representative, Parent
will purchase from the Surviving Corporation, in addition to the securities
described in Section 5.04(a), (i) an additional Debenture in the principal
amount of at least Two Hundred Thousand Dollars ($200,000) on or before December
31, 2006 at a purchase price equal to such principal amount, and (ii) an
additional two hundred (200) shares of Series B Preferred Stock at a cost of Two
Hundred Thousand Dollars ($200,000) on or before December 31, 2006.

     (c) Each party hereto agrees that notwithstanding anything else in this
Agreement, the provisions of this Section 5.04 shall survive the Merger.

     SECTION 5.05. Securities Matters.

     (a) Each Shareholder acknowledges and agrees that "stop transfer"
instructions shall be placed against the shares of Series A Preferred Stock
issued in accordance with Section

                                       27
<PAGE>

1.07 on the transfer books of the Buyer's stock transfer agent until such time
as the shares of Series A Preferred Stock and such shares are available for
resale in accordance with all applicable law and the terms of the Shareholders'
Agreement and that the certificates evidencing the shares of Series A Preferred
Stock and such shares shall bear the following legend:

     THE SHARES OF SERIES A PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE HAVE
     NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER
     ANY APPLICABLE STATE SECURITIES LAWS AND NEITHER THE SHARES NOR ANY
     INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF
     IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER
     SUCH ACT AND THE RULES AND REGULATIONS THEREUNDER AND IN THE ABSENCE OF
     REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER ANY APPLICABLE STATE
     SECURITIES LAWS. THE TRANSFER OF THE SHARES IS ALSO SUBJECT TO THE
     RESTRICTIONS SET FORTH IN THAT CERTAIN SHAREHOLDERS' AGREEMENT DATED
     JANUARY 6, 2006 BETWEEN THE COMPANY AND THE REGISTERED OWNER OF THE SHARES.

     (b) Parent acknowledges and agrees that the Debenture, the Administrative
Services Debenture, and certificates evidencing the shares of Series B Preferred
Stock or Common Stock shall bear the following legend:

     THE SHARES OF SERIES A PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE HAVE
     NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER
     ANY APPLICABLE STATE SECURITIES LAWS AND NEITHER THE SHARES NOR ANY
     INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF
     IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER
     SUCH ACT AND THE RULES AND REGULATIONS THEREUNDER AND IN THE ABSENCE OF
     REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER ANY APPLICABLE STATE
     SECURITIES LAWS.

     SECTION 5.06. Insurability of Thomas. Thomas hereby represents and
warranties that he is in good physical health, and shall qualify to underwritten
at a standard rate for a "key man" life insurance policy to be purchased by the
Surviving Corporation, naming the Surviving Corporation as the beneficiary.
Thomas hereby agrees to use commercially reasonable efforts to assist the
Company in applying for such a policy.

                                       28
<PAGE>

     SECTION 5.07. Non-Disclosure of Confidential Information and
Non-Solicitation.

     (a) Each Shareholder acknowledges that such Shareholder has been informed
that it is the policy of the Company, and will be a policy of the Surviving
Corporation, to maintain as secret and confidential all information

          (i) relating to the products, processes, designs and/or systems used
     by the Company, the Surviving Corporation and their respective Affiliates;
     and

          (ii) relating to the customers and employees of the Company, the
     Surviving Corporation and their respective affiliates (all such information
     hereafter referred to as "confidential information"), and the Executive
     further acknowledges that such confidential information is of great value
     to the Company.

     (b) The parties recognize that, by reason of their interests and, as
applicable, employment with the Company, each Shareholder has acquired
confidential information as aforesaid. The parties confirm that it is reasonably
necessary to protect the Surviving Corporation's goodwill, and accordingly each
Shareholder does agree that such Shareholder will not directly or indirectly
(except where authorized by the Board of Directors of the Surviving Corporation
for the benefit of the Surviving Corporation):

          (i) At any time prior to the third (3rd) anniversary of this
     Agreement, divulge to any persons, firms or corporations, other than the
     Surviving Corporation (hereinafter referred to collectively as "third
     parties"), or use or allow or cause or authorize any third parties to use,
     any such confidential information, except in furtherance of the business of
     the Surviving Corporation;

          (ii) At any time prior to the third (3rd) anniversary of this
     Agreement, solicit or cause or authorize directly or indirectly to be
     solicited, for or on behalf of such Shareholder or third parties, any
     business from persons, firms, corporations or other entities who were at
     any time prior to the third (3rd) anniversary of this Agreement, customers
     of the Surviving Corporation or its affiliates, except in furtherance of
     the business of the Surviving Corporation and further except in the case of
     a product or service not in competition with a product or service of the
     Surviving Corporation;

          (iii) At any time prior to the third (3rd) anniversary of this
     Agreement, accept or cause or authorize directly or indirectly to be
     accepted, for or on behalf of such Shareholder or third parties, any
     business from any such customers of the Company, the Surviving Corporation
     or their respective affiliates, except in furtherance of the business of
     the Surviving Corporation and further except in the case of a product or
     service not in competition with a product or service of the Surviving
     Corporation;

          (iv) At any time prior to the third (3rd) anniversary of this
     Agreement, solicit or cause or authorize directly or indirectly to be
     solicited for employment, for or on behalf of such Shareholder or third
     parties, any persons (excluding any individuals residing in the same
     immediate primary residence as such Shareholder, and/or such Shareholder's
     immediate family) who were at any time prior to the third (3rd) anniversary
     of this

                                       29
<PAGE>

     Agreement, employees of the Company, the Surviving Corporation or their
     respective affiliates; and

          (v) At any time prior to the third (3rd) anniversary of this
     Agreement, employ or cause or authorize directly or indirectly to be
     employed, for or on behalf of such Shareholder or third parties, any such
     employees of the Company or its affiliates.

     (c) Each Shareholder agrees that, upon the consummation of the Merger, such
Shareholder shall forthwith deliver up to the Surviving Corporation any and all
records, drawings, notebooks, keys and other documents and material, and copies
thereof in his or her possession or under his control which is the property of
the Company or which relate to any confidential information or any discoveries
of the Company.

     (d) Each Shareholder agrees that any breach or threatened breach by such
Shareholder of any provision of this Section 5.07 shall entitle the Surviving
Corporation, in addition to any other legal remedies available to it, to enjoin
such breach or threatened breach through any court of competent jurisdiction.
The parties understand and intend that each restriction agreed to by a
Shareholder herein above shall be construed as separable and divisible from
every other restriction, and that the unenforceability, in whole or in part, of
any restriction will not affect the enforceability of the remaining
restrictions, and that one or more or all of such restrictions may be enforced
in whole or in part as the circumstances warrant.

                                   ARTICLE VI

                            CONDITIONS TO THE MERGER

     SECTION 6.01. Conditions to Obligation of Each Party to Effect the Merger.
The respective obligations of each party to effect the Merger shall be subject
to the satisfaction at or prior to the Effective Time of the following
conditions:

     (a) Governmental Actions. There shall not have been instituted, pending or
threatened any action or proceeding (or any investigation or other inquiry that
is reasonably likely to result in such an action or proceeding) by any
governmental authority or administrative agency before any governmental
authority, administrative agency or court of competent jurisdiction, United
States or non-United States, that is reasonably likely to result in an order,
nor shall there be in effect any judgment, decree or order of any governmental
authority, administrative agency or court of competent jurisdiction, or any
other legal restraint (i) preventing or seeking to prevent consummation of the
Merger or (ii) as a condition to the obligations of Parent and Merger Sub,
prohibiting or seeking to prohibit, or limiting or seeking to limit, Parent from
exercising all material rights and privileges pertaining to its equity ownership
in the Surviving Corporation or any investor in Parent from owning and
exercising all material rights and privileges pertaining to its ownership of its
interest therein or the ownership in Parent, or compelling or seeking to compel
Parent to dispose of or hold separate all or any material portion of the
business or assets of Parent (including the Surviving Corporation), as a result
of the Merger or the transactions contemplated by this Agreement;

                                       30
<PAGE>

     (b) Employment Agreements. (i) Thomas shall have executed the Thomas
Employment Agreement and delivered it to the Merger Sub, to be held by the
Merger Sub and released to the Surviving Corporation subject only to the
effectiveness of the Merger; and (ii) Lucas shall have executed the Lucas
Employment Agreement and delivered it to the Merger Sub, to be held by the
Merger Sub and released to the Surviving Corporation subject only to the
effectiveness of the Merger;

     (c) Shareholders' Agreement. (i) Each Shareholder and the Merger Sub shall
have entered into a Shareholders' Agreement substantially in the form attached
hereto as Exhibit E (the "Shareholders' Agreement"); and

     (d) Illegality. No statute, rule, regulation or order shall be enacted,
entered, enforced or deemed applicable to the Merger which makes the
consummation of the Merger illegal.

     SECTION 6.02. Additional Conditions to Obligations of Parent and Merger
Sub. The obligations of Parent and Merger Sub to effect the Merger are also
subject to the following conditions:

     (a) Representations and Warranties. The representations and warranties of
the Company contained in this Agreement shall be true and correct in all
respects (without for this purpose giving effect to qualifications of
materiality contained in such representations and warranties) at and as of the
Effective Time, with the same force and effect as if made at and as of the
Effective Time, except for (i) changes contemplated by this Agreement, or (ii)
those representations and warranties which address matters only as of a
particular date (which shall have been true and correct as of such date), and
Parent and Merger Sub shall have received a certificate of the Company to such
effect signed by the Chief Executive Officer of the Company;

     (b) Agreements and Covenants. The Company shall in all material respects
have performed or complied with the agreements and covenants required by this
Agreement to be performed or complied with by it on or prior to the Effective
Time, and Parent and Merger Sub shall have received a certificate to such effect
signed by the Chief Executive Officer of the Company;

     (c) Consents Obtained. All material consents, waivers, approvals,
authorizations or orders required to be obtained, and all filings required to be
made, by the Company for the authorization, execution and delivery of this
Agreement and the consummation by it of the transactions contemplated hereby
shall have been obtained and made by the Company, including any consents
required pursuant to each of the customer and supplier contracts listed on
Schedule 6.02(c) hereto, except where the failure to receive such consents,
waivers, approvals, authorizations or orders would not, individually or in the
aggregate with all other such failures, have a Material Adverse Effect on the
Company or Parent; provided, however, that the failure to obtain any consent
required pursuant to any contract listed on Schedule 6.02(c) hereto shall be
deemed by the parties hereto to constitute such a Material Adverse Effect;

     (d) Secretary's Certificate. Parent and Merger Sub shall have received a
Secretary's Certificate of the Company in form and substance reasonably
satisfactory to Parent

                                       31
<PAGE>

and Merger Sub certifying, among other things, the Company's organizational
documents and resolutions of its board of directors relating to the approval of
this Agreement and the transactions contemplated hereby; and

     (e) Shareholders shall have delivered certificates for the Shares for
surrender to the Company for cancellation in accordance with Section 1.07 of
this Agreement upon the consummation of the Merger.

     SECTION 6.03. Additional Conditions to Obligation of the Company. The
obligation of the Company to effect the Merger is also subject to the following
conditions:

     (a) Representations and Warranties. The representations and warranties of
Parent and Merger Sub contained in this Agreement shall be true and correct in
all respects (without for this purpose giving effect to qualifications of
materiality contained in such representations and warranties) at and as of the
Effective Time, with the same force and effect as if made at and as of the
Effective Time, except for (i) changes contemplated by this Agreement and (ii)
those representations and warranties which address matters only as of a
particular date (which shall have been true and correct as of such date), and
the Company and Shareholders shall have received a certificate to such effect
signed by the Chief Executive Officer of Parent;

     (b) Agreements and Covenants. Parent and Merger Sub shall in all material
respects have performed or complied with the agreements and covenants required
by this Agreement to be performed or complied with by them on or prior to the
Effective Time, and the Company and Shareholders shall have received a
certificate of Parent and Merger Sub to such effect signed by the Chief
Executive Officer or President of Merger Sub;

     (c) Consents Obtained. All material consents, waivers, approvals,
authorizations or orders required to be obtained, and all filings required to be
made, by Parent or Merger Sub for the authorization, execution and delivery of
this Agreement and the consummation by them of the transactions contemplated
hereby shall have been obtained and made by Parent or Merger Sub, except where
the failure to receive such consents, waivers, approvals, authorizations or
orders would not, individually or in the aggregate with all other such failures,
have a Material Adverse Effect on the Merger Sub or Parent;

     (d) Sale of Series B Preferred Stock and Debentures. At or prior to the
Closing, Parent shall purchase from the Merger Sub (i) three hundred twenty five
(325) shares of Series B Preferred Stock of the Merger Sub for an aggregate of
Three Hundred Twenty Five Thousand Dollars ($325,000) and (ii) a Debenture in a
principal amount of Three Hundred Sixty Thousand Dollars ($360,000) at par,
which shall automatically convert into an obligation of the Surviving
Corporation at the Effective Time; and

     (e) Secretary's Certificate. The Company and Shareholders shall have
received a Secretary's Certificate of the Merger Sub in form and substance
reasonably satisfactory to the Company certifying, among other things, the
Merger Sub's organizational documents and resolutions of its board of directors
relating to the approval of this Agreement and the transactions contemplated
hereby.

                                       32
<PAGE>

                                   ARTICLE VII

                                 INDEMNIFICATION

     SECTION 7.01. Survival of Representations and Warranties. The
representations and warranties of the parties herein contained shall survive the
Closing for a period of three (3) years, except in the case of representations
contained Section 2.15, which shall survive until the expiration of the
applicable statute of limitations, notwithstanding any investigation at any time
made by or on behalf of the other party. Any claims for indemnification in
accordance with this Article VII with respect to any representation or warranty
must be made (and will be null and void unless made) on or before such date
(except in the case of representations contained in Section 2.03 and 2.15, which
must be made within six (6) months following the expiration of the applicable
statute of limitations).

     SECTION 7.02. Indemnification by the Shareholders and the Company.

     (a) General. The Major Shareholders and the Company, jointly and severally,
hereby agree to indemnify and hold the Parent and the Merger Sub and their
respective successors, assigns, officers, directors, stockholders, affiliates,
employees, representatives and other agents harmless from and against any and
all claims, liabilities, taxes, losses, damages or injuries, together with costs
and expenses, including reasonable legal fees ("Damages"), arising out of or
resulting from (i) any breach, misrepresentation or material omission of the
representations and warranties made by any Shareholders or the Company in this
Agreement or in any Schedule or Exhibit hereto or other documents delivered in
connection herewith, (ii) any breach in any material respect by any Shareholder
or the Company, unless waived in writing by Parent, of any covenant or agreement
contained in or arising out of this Agreement, or any other agreement delivered
in connection herewith on the Closing Date, and (iii) any and all sales, use,
value added, stamp, transfer or other similar taxes arising from the
transactions contemplated herein, (iv) any and all liabilities of the Company
arising, existing or accruing prior to the Closing Date (including liability for
Taxes), except those liabilities for which adequate financial reserves have been
reflected in the Financial Statements. Each Shareholder and the Company, jointly
and severally, hereby agrees to indemnify and hold the Parent and the Merger Sub
and its successors, assigns, officers, directors, stockholders, affiliates,
employees, representatives and other agents harmless from and against any and
all Damages, arising out of or resulting from (i) any breach, misrepresentation
or material omission of the representations and warranties made by any
Shareholder or the Company in this Agreement or other documents delivered by any
Shareholder or the Company in connection herewith and (ii) any breach in any
material respect by any Shareholder or the Company, unless waived in writing by
the Buyer, of any covenant or agreement of any Shareholder or the Company
contained in or arising out of this Agreement, or any other agreement delivered
by any Shareholder or the Company in connection herewith on the Closing Date.

     (b) Limitation. Notwithstanding anything to the contrary herein, (x) the
aggregate liability of the Major Shareholders for Damages under this Article VI
shall not exceed One Million Five Hundred Thousand Dollars ($1,500,000) and the
liability of each Major Shareholder shall be joint and several; provided,
however, that there shall be no limitation of the

                                       33
<PAGE>

aggregate liability of the Major Shareholders for Damages relating to Taxes.
Nothing in this Agreement including this Section 7.02(b) shall limit or restrict
the Parent or Merger Sub's right to maintain or recover any amounts in
connection with any action or claim based upon fraudulent misrepresentation or
deceit.

     SECTION 7.03. Indemnification by Parent and Merger Sub.

     (a) General. Parent and Merger Sub, jointly and severally, hereby agree to
indemnify and hold the Shareholders and the Company and their respective
successors, assigns, officers, directors, stockholders, affiliates, employees,
representatives and other agents harmless from and against any and all Damages,
arising out of or resulting from (i) any breach, misrepresentation or material
omission of the representations and warranties made by Parent or Merger Sub in
this Agreement or other documents delivered by Parent or Merger Sub in
connection herewith and (ii) any breach in any material respect by Parent or
Merger Sub, unless waived in writing by the Shareholder Representative, of any
covenant or agreement of Parent or Merger Sub contained in or arising out of
this Agreement (including, without limitation, the obligations of the Parent to
the Surviving Company pursuant to Section 5.04), or any other agreement
delivered by Parent or Merger Sub in connection herewith on the Closing Date.

     (b) Limitation. Notwithstanding anything to the contrary herein, (x) the
aggregate liability of the Parent and Merger Sub for Damages under this Article
VII shall not exceed One Million Five Hundred Thousand Dollars ($1,500,000) and
the liability of Parent and Merger Sub shall be joint and several. Nothing in
this Agreement including this Section 7.03(b) shall limit or restrict the
Shareholders' or Company's right to maintain or recover any amounts in
connection with any action or claim based upon fraudulent misrepresentation or
deceit.

     SECTION 7.04. Procedure of Indemnification.

     (a) Claim Notice. Any party claiming a right to indemnification hereunder
(the "Indemnified Party") shall give the other party from whom indemnification
is sought (the "Indemnifying Party") prompt written notice (a "Claim Notice") of
any claim, demand, action, suit, proceeding or discovery of fact upon which the
Indemnified Party intends to base a claim for indemnification under this Article
VII, which shall contain (x) a description (specifying in detail the facts and
circumstances with respect to such claim) and the amount (the "Claimed Amount")
of any Damages incurred or reasonably expected to be incurred by the Indemnified
Party, (y) a statement that the Indemnified Party is entitled to indemnification
under this Article VII for such Claimed Amount, and (z) a demand for payment;
provided, however, that no failure to give such Claim Notice shall excuse any
Indemnifying Party from any obligation hereunder except to the extent the
Indemnifying Party is materially prejudiced by such failure.

     (b) Assistance. The Indemnified Party shall make available to the
Indemnifying Party and its counsel and accountants, all books and records of the
Indemnified Party relating to such action, suit or proceeding and the parties
agree to render to each other such assistance as may reasonably be requested in
order to insure the proper and adequate defense of any such action, suit or
proceeding.

                                       34
<PAGE>

     (c) Assumption of Defense. Regarding claims asserted under this Section
7.04 and involving third party claims, within 20 days after delivery of the
Claim Notice, the Indemnifying Party may, upon written notice thereof to the
Indemnified Party, assume control of the defense of such suit or proceeding with
counsel reasonably satisfactory to the Indemnified Party; provided, however,
that the Indemnifying Party shall not be entitled to control and the Indemnified
Party shall be entitled to have sole control over any claim to the extent such
claim seeks an order, injunction or other equitable relief against the
Indemnified Party which, if successful, could materially interfere with the
business, operations, assets, condition (financial or otherwise) or prospects of
the Indemnified Party or relates to Taxes reflected or to be reflected in a Tax
Return of the Indemnified Party, provided that the Indemnified Party shall
provide written notice to the Indemnifying Party of its election to assume
control over the defense of such claim pursuant to this Section 7.04. If the
Indemnifying Party does not so assume control of such defense within said 20 day
period, the Indemnified Party shall control such defense. The party not
controlling such defense (the "Non-controlling Party") shall be entitled to
participate therein at its own expense; provided that if the Indemnifying Party
assumes control of such defense and the Indemnified Party reasonably concludes
that the Indemnifying Party and the Indemnified Party have conflicting interests
or different defenses available with respect to such suit or proceeding, the
Indemnified Party shall have the right to select a separate counsel and to
assume such legal defenses and otherwise to participate in the defense of such
action, with the reasonable fees and expenses of counsel to the Indemnified
Party being considered "Damages" for purposes of this Agreement. Except in a
case of such conflict, the party controlling such defense (the "Controlling
Party") shall keep the Non-controlling Party advised of the status of such suit
or proceeding and the defense thereof and shall consider in good faith
recommendations made by the Non-controlling Party with respect thereto. The
Non-controlling Party shall furnish the Controlling Party with such information
as it may have with respect to such suit or proceeding (including copies of any
summons, complaint or other pleading which may have been served on such party
and any written claim, demand, invoice, billing or other document evidencing or
asserting the same) and shall otherwise cooperate with and assist the
Controlling Party in the defense of such suit or proceeding. The Indemnified
Party shall not agree to any settlement of or consent to the entry of any
judgment arising from any suit or proceeding without the consent of the
Indemnifying Party which consent shall not be unreasonably withheld or delayed.
The Indemnifying Party shall not agree to any settlement of, or the entry of any
judgment arising from, any such suit or proceeding without the prior written
consent of the Indemnified Party, which shall not be unreasonably withheld or
delayed; provided that the consent of the Indemnified Party shall not be
required if the Indemnifying Party agrees in writing to pay any amounts payable
pursuant to such settlement or judgment and such settlement or judgment includes
a complete release of the Indemnified Party from further liability and has no
other adverse effect on the Indemnified Party.

     (d) Indemnity Response. Within 20 days after delivery of a Claim Notice,
the Indemnifying Party shall deliver to the Indemnified Party a written response
(the "Response") in which the Indemnifying Party shall: (x) agree that the
Indemnified Party is entitled to receive promptly all of the Claimed Amount, by
check or by wire transfer), (y) agree that the Indemnified Party is entitled to
receive part, but not all, of the Claimed Amount (the "Agreed Amount") (in which
case the Response shall be accompanied by a payment by the Indemnifying Party to
the Indemnified Party of the Agreed Amount, by check or by wire transfer), or
(z) dispute that the Indemnified Party is entitled to receive any of the Claimed
Amount. If the

                                       35
<PAGE>

Indemnifying Party in the Response disputes its liability for all or part of the
Claimed Amount, the Response (if one has been provided) shall set forth in
detail the basis for the objection.

     (e) Minimum Threshold For Indemnification. Notwithstanding any provision to
the contrary contained in this Agreement:

          (i) no party shall be obligated to indemnify any other party for any
     Damages pursuant to this Article VII unless the total of all Damages
     payable by such party shall equal, in the aggregate, Five Thousand Dollars
     ($5,000); provided, however, if such Damages do, in the aggregate, exceed
     Five Thousand Dollars ($5,000), then the Indemnifying Party shall be liable
     for the full amount of such Damages including such Five Thousand Dollars
     ($5,000); and

          (ii) any amounts which any party hereto may be obligated to pay
     another party hereto shall be reduced by an amount equal to any insurance
     actually received by the Indemnified Party with respect to such Damages.

     (f) Subrogation. In the event that the Indemnifying Party shall be
obligated to indemnify the Indemnified Party pursuant to this Article VII, the
Indemnifying Party shall, upon payment of such indemnity in full, be subrogated
to all rights of the Indemnified Party with respect to the claim to which such
indemnification relates.

                                  ARTICLE VIII

                               GENERAL PROVISIONS

     SECTION 8.01. Effectiveness of Representations, Warranties and Agreements.

     (a) The representations, warranties and agreements of each party hereto
shall remain operative and in full force and effect regardless of any
investigation made by or on behalf of any other party hereto, any person
controlling any such party or any of their officers or directors, whether prior
to or after the execution of this Agreement.

     (b) Any disclosure made with reference to one or more Sections of the
Company Disclosure Schedule shall be deemed disclosed with respect to each other
section therein as to which such disclosure is relevant provided that such
relevance is reasonably apparent. Disclosure of any matter in the Company
Disclosure Schedule shall not be deemed an admission that such matter is
material. No statement contained in any certificate or schedule required to be
furnished by any party hereto pursuant to the provisions of this Agreement,
including the Company Disclosure Schedule shall contain any untrue statement of
material fact.

     SECTION 8.02. Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly given
or made if and when delivered personally, against written receipt thereof, or by
overnight courier to the parties at the following addresses or sent by
electronic transmission, with confirmation received, to the telecopy numbers
specified below (or at such other address or telecopy number for a party as
shall be specified by like notice):

                                       36
<PAGE>

     (a) If to Parent, Merger Sub or Surviving Company:

                                    iVoice, Inc.
                                    750 Highway 34
                                    Matawan, New Jersey
                                    07747
                                    Attn: Jerry Mahoney
                                    Telecopy: (732) 441-7700
                                    Confirm:  (732) 441-9895

                           With a copy to:

                                    Kramer Levin Naftalis & Frankel LLP
                                    1177 Avenue of the Americas
                                    New York, NY  10036
                                    Attn: Scott Rosenblum, Esq.
                                    Telecopy: (212) 715-8000
                                    Confirm:  (212) 715-9100

     (b) If to the Company:

                                    Thomas Pharmaceuticals Ltd.
                                    320 West 22nd Street - Suite 3A
                                    New York, New York 10011
                                    Attn: Farris M. Thomas, Jr.
                                    Telecopy: (212) 253-0501
                                    Confirm:  (212) 253-0008

                           With a copy to:

                                    Snow Becker Krauss P.C.
                                    605 Third Avenue - 25th Floor
                                    New York, New York 10158
                                    Attention: Jack Becker, Esq.
                                    Telecopy: 212-949-7052
                                    Confirm:  212-687-3860

     (c) If to the Shareholders, then to the address listed on the applicable
Shareholder's counterpart signature page.

     SECTION 8.03. Certain Definitions. For purposes of this Agreement, the
term:

     (a) "affiliates" means a person that directly or indirectly, through one or
more intermediaries, controls, is controlled by, or is under common control
with, the first mentioned person;

     (b) "business day" means any day other than a day on which banks in New
York are required or authorized to be closed;

                                       37
<PAGE>

     (c) "control" (including the terms "controlled by" and "under common
control with") means the possession, directly or indirectly or as trustee or
executor, of the power to direct or cause the direction of the management or
policies of a person, whether through the ownership of stock, as trustee or
executor, by contract or credit arrangement or otherwise;

     (d) "dollars" or "$" means United States dollars;

     (e) "knowledge" or "best knowledge" means, with respect to any matter in
question, that the Responsible Officers of the Company or Parent or Merger Sub,
as the case may be, have or at any time had actual knowledge of such matters.
"Responsible Officers" for purposes of this definition means the Chief Executive
Officer, the President, any Executive or Senior Vice President or Corporate Vice
President, the Chief Financial Officer or the General Counsel of any such
person;

     (f) "person" means an individual, corporation, partnership, limited
liability company, association, trust, unincorporated organization, other entity
or group (as defined in Section 13(d)(3) of the Exchange Act); and

     (g) "subsidiary" or "subsidiaries" of the Company, the Surviving
Corporation, Parent or any other person means any corporation, partnership,
joint venture or other legal entity of which the Company, the Surviving
Corporation, Parent or such other person, as the case may be (either alone or
through or together with any other subsidiary), owns, directly or indirectly,
more than 50% of the stock or other equity interests the holders of which are
generally entitled to vote for the election of the board of directors or other
governing body of such corporation or other legal entity.

     SECTION 8.04. Amendment. This Agreement may be amended by the parties
hereto by at any time prior to the Effective Time. This Agreement may not be
amended except by an instrument in writing signed by the parties hereto.

     SECTION 8.05. Waiver. Any party hereto may with respect to any other party
hereto (a) extend the time for the performance of any of the obligations or
other acts, (b) waive any inaccuracies in the representations and warranties
contained herein or in any document delivered pursuant hereto, or (c) waive
compliance with any of the agreements or conditions contained herein. Any such
extension or waiver shall be valid if set forth in an instrument in writing
signed by the party or parties to be bound thereby.

     SECTION 8.06. Headings. The headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.

     SECTION 8.07. Severability.

     (a) If any term or other provision of this Agreement is invalid, illegal or
incapable of being enforced by any rule of law or public policy, all other
conditions and provisions of this Agreement shall nevertheless remain in full
force and effect so long as the economic or legal substance of the transactions
contemplated hereby is not affected in any manner adverse to any

                                       38
<PAGE>

party. Upon a determination that any term or other provision is invalid, illegal
or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of the parties as
closely as possible in an acceptable manner to the end that the transactions
contemplated hereby are fulfilled to the extent possible.

     SECTION 8.08. Entire Agreement. This Agreement, together with the other
Transaction Documents, constitutes the entire agreement and supersedes all prior
agreements and undertakings, both written and oral, among the parties, or any of
them, with respect to the subject matters hereof and thereof, except as
otherwise expressly provided herein.

     SECTION 8.09. Assignment. This Agreement shall not be assigned by operation
of law or otherwise, except that all or any of the rights of Parent and/or
Merger Sub hereunder may be assigned to any wholly-owned, direct or indirect,
subsidiary of Parent, provided that no such assignment shall relieve the
assigning party of its obligations hereunder.

     SECTION 8.10. Parties in Interest. This Agreement shall be binding upon and
inure solely to the benefit of each party hereto, and nothing in this Agreement,
express or implied, is intended to or shall confer upon any other person any
right, benefit or remedy of any nature whatsoever under or by reason of this
Agreement, including, without limitation, by way of subrogation, other than
Article VII (which is intended to be for the benefit of the indemnified persons
identified therein and may be enforced by such indemnified persons).

     SECTION 8.11. Failure or Indulgence Not Waiver; Remedies Cumulative. No
failure or delay on the part of any party hereto in the exercise of any right
hereunder shall impair such right or be construed to be a waiver of, or
acquiescence in, any breach of any representation, warranty or agreement herein,
nor shall any single or partial exercise of any such right preclude any other or
further exercise thereof or of any other right. All rights and remedies existing
under this Agreement are cumulative to, and not exclusive of, any rights or
remedies otherwise available.

     SECTION 8.12. Governing Law; Jurisdiction.

     (a) This Agreement shall be governed by, and construed in accordance with,
the internal laws of the State of New York applicable to contracts executed and
fully performed within the State of New York.

     (b) Each of the parties hereto submits to the exclusive jurisdiction of the
state and federal courts of the United States located in the State of New York
with respect to any claim or cause of action arising out of this Agreement or
the transactions contemplated hereby.

     (c) Each of the parties to this Agreement (i) consents to submit itself to
the personal jurisdiction of such court in the event that any dispute arises out
of this Agreement or any of the transactions contemplated by this Agreement,
(ii) agrees that it will not attempt to deny or defeat such personal
jurisdiction by motion or other request for leave from any such court and (iii)
agrees that it will not bring any action in relation to this Agreement, the
Merger or any of the other transactions contemplated by this Agreement in any
court other than such court in the State of New York.

                                       39
<PAGE>

     SECTION 8.13. Counterparts. This Agreement may be executed in two or more
counterparts, and by the different parties hereto in separate counterparts, each
of which when executed shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.

     SECTION 8.14. WAIVER OF JURY TRIAL. EACH OF PARENT, MERGER SUB AND THE
COMPANY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ALL
RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM (WHETHER
BASED UPON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY.

     SECTION 8.15. Performance of Obligations. Unless otherwise previously
performed, Parent shall cause Merger Sub to perform all of its obligations set
forth in this Agreement.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       40
<PAGE>

     IN WITNESS WHEREOF, Parent, Merger Sub, the Company and the Shareholders
have caused this Agreement to be executed as of the date first written above by
their respective officers thereunto duly authorized.

                                         IVOICE, INC.

                                         By ______________________________
                                            Name:
                                            Title:

                                         THOMAS PHARMACEUTICALS, LTD.
                                         (f/k/a iVoice Acquisition Corp.)

                                         By ______________________________
                                            Name:
                                            Title:

                                         THOMAS PHARMACEUTICALS LTD.

                                         By ______________________________
                                            Name:
                                            Title:

                                       41
<PAGE>

                                         ______________________________
                                         FARRIS M. THOMAS, JR.

                                         Address:

                                         320 West 22nd Street
                                         New York, New York 10011

                                         Fax:

                                       42
<PAGE>

                                         ______________________________
                                         JOHN E. LUCAS

                                         Address:

                                         1255 North Gulfstream Avenue
                                         Apartment 703
                                         Sarasota, Florida 34236

                                         Fax:

                                       43
<PAGE>

                                         ______________________________
                                         RICHARD C. BROGLE

                                         Address:

                                         8 Kenneth Lane
                                         Upper Montclair
                                         New Jersey 07043

                                         Fax:

                                       44
<PAGE>

                                         ______________________________
                                         NINA SCHWALBE

                                         Address:

                                         55 White Street
                                         New York, New York 10013

                                         Fax:

                                       45
<PAGE>

                                         ______________________________
                                         JOHN H. KIRKWOOD

                                         Address:

                                         2030 Union Street
                                         San Francisco
                                         California 94123

                                         Fax:

                                       46
<PAGE>

                                         ______________________________
                                         MAUREEN GILLESPIE

                                         Address:

                                         32 West 31st Street
                                         Studio 7
                                         New York, New York 10001

                                         Fax:

                                       47

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]